A cluster of two serine transfer RNA genes from Clostridium acetobutylicum P262 by Sealy, Victoria Rosamond
Un
ive
sit
y o
f C
ap
e T
ow
n
A cluster of two serine transfer RNA genes 
from Clostridium acetobutylicum P262 
Victoria Rosanlond Sealy 
In partial fulfIllment of the requirements for the degree of Master of Science 

in the Faculty of Science, 

University of Cape Town. 

CapeTown 
December 1993 
  
 
 
 
 
 
 
 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
Acknowledgements 

Thanks to my supervisors, Prof. Dave Woods and Dr. Shez Reid for their enthusiasm 
and advice and also for financial support. Thanks also to the members of the 
Microbiology Department for creating a stimulating and fun environment and 
especially to members of the Anaerobe Unit for help and advice. Thanks to Di 
James for help with the sequencing and Will Bourn for finding the LexA site. Many 
thanks to Ann Jaffray and Di de Villiers for the expert running of the technical side 
of the department. Ernest Clarke deserves many thanks for all the washing up and 
media. Many people helped proofread this thesis and their help was much 
appreciated: Helen Collett, Dr. Heide Goodman, Brendan Babb and Dr. Val Abratt. 
Special thanks also to Brendan Babb for lots of computer assistance. Mostly, thanks 
to my parents for their encouragement and financial support and Porky, for walks. I 
acknowledge financial assistance from the Foundation for Research Development. 
Contents 
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 

Abbreviations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 111 

List of Figures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v 

Chapter One 

Literature review and introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 

Chapter Two 

The molecular characterization of plasmid pMETIOB . . . . . . . . . . . . . . .. 35 

Chapter Three 

Nucleotide sequencing and RNA studies. . . . . . . . . . . . . . . . . . . . . . .. 55 

Chapter Four 

General discussion and conclusion. . . . . . . . . . . . . . . . . . . . . . . . . . .. 73 

Appendix. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 78 

Literature cited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 105 

1 
Abstract 

A cloning system, using metronidazole as a screening tool and E. coli FI9 as a 
selection host, was previously established to clone C. acetobutylicum P262 
electron transport genes which may play a role in solvent metabolism in this 
bacterium. In theory, metronidazole would be reduced under anaerobic 
conditions to a cytotoxic intermediate by C. acetobutylicum P262 electron 
transport genes or reductive enzymes cloned into a recombinant plasmid. This 
intermediate would kill the host E. coli FI9. One C. acetobutylicum P262 
clone, pMETIOB, was found to render the E. coli strain FI9 sensitive to 
metronidazole, under anaerobic conditions. A number of subclones of the 
2.56kb C. acetobutylicum P262 insert DNA were generated in Bluescript pKS 
and pSK. A range of exonuclease III deletions of this C. acetobutylicum P262 
insert DNA were also generated which were shown to lose the metronidazole 
sensitivity phenotype on progressive deletion of the insert DNA. In vitro and 
in vivo protein transcription/translation experiments failed to reveal a protein 
product that was related to the metronidazole sensitivity phenotype. DNA 
hybridization confrrmed that the insert DNA of pMETIOB hybridized to 
C. acetobutylicum P262 chromosomal DNA, but not to E. coli chromosomal 
DNA. 
The nucleotide sequence of a 933-bp fragment of the C. acetobutylicum P262 
insert DNA was determined. DNA homology searches revealed two serine 
tRNA genes with the unmodified anticodons UGA and GCU that corresponded 
to the serine codons UCA and AGC, respectively. A putative promoter that 
had strong homology to both consensus E. coli promoter regions and consensus 
Gram positive promoter regions, was located upstream of the tRNASer genes. 
A 7-bp sequence showed homology to a stringent control region from 
11 
B. subtilis. Three I3-bp repeat sequences located immediately after the two 
tRNASer genes were identified as a rho-independent transcription terminator. 
The position of the tRNASer genes on the exonuclease III-shortened clones 
indicated that they were not related to the ability of certain of the constructs to 
render E. coli FI9 sensitive to metronidazole. Instead, a I6-bp sequence, that 
showed homology to a consensus LexA binding site from E. coli, appeared to 
be related to the metronidazole sensitivity phenotype. We speculate that this 
sequence may mimick an E. coli LexA binding site which may cause the 
autoregulated lexA structural gene to overexpress the protein. The increased 
expression of LexA may generate the sensitivity phenotype observed by 
placing an increased load on the transciption and translation machinery of the 
cell. In this laboratory only one of five C. acetobutylicum P262 clones, that 
conferred the metronidazole sensitivity phenotype on E. coli F19, was 
identified to contain genes related to electron transport. We therefore propose 
that a more specific strategy be adopted for the cloning of electron transport 
genes in C. acetobutylicum P262. 
The isolation of the tRNASer genes was fortunate in that only one tRNA gene 
has previously been cloned from C. acetobutylicum P262. The stringent 
control element upstream of the tRNASer genes also provided the fust 
indication that the stringent response may operate in C. acetobutylicum P262. 
The location of putative transcriptional control elements and preliminary RNA 
hybridization experiments indicated that the tRNASer genes may be transcribed 
as one transcriptional unit. This provides the fust information about tRNA 
gene organisation in C. acetobutylicum P262. 
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Chapter One 

Literature review and introduction 

1.1 Clostridium acetobutylicum 
Clostridium acetobutylicum is a Gram-positive, spore-fonning bacterium that has 
been used in the past for the production of acetone and butanol via fermentation in 
large-scale industrial processes. In spite of the decline in the use of the AB 
(acetone-butanol) fermentation in the 1960's due to economic competition from 
chemically produced solvents, there has recently been renewed interest in the 
fermentation process. The rise in the petroleum price in the 1970's, the prospect of 
the exhaustion of the world's fossil fuel supply and the popularity of 
environmentally "friendly" products, all point to the feasibility of once agaIn 
obtaining fuel by the microbial fermentation of renewable resources. 
1.1.1 History of the acetone-butanol fermentation 
Louis Pasteur was the frrst person to observe the production of butanol by a 
"Vibrion butyrique" in 1861. This bacterium probably belonged to the genus 
Clostridium (Morris, 1993). It was not, however, until the First World War that the 
study of the clostridia was initiated for two reasons. Firstly, gangrenous clostridial 
infection of wounds became common, and secondly, the demand for acetone in the 
manufacture of explosives increased. C. acetobutylicum was therefore used in 
industrial fermentations to supply the acetone requirements of the munitions 
industry. The history of the AB fermentation has been reviewed extensively by 
Jones and Woods (1986) and by Morris (1993). Both reviews have provided the 
basis for much of the information presented here. 
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The ftnn of Strange and Graham Ltd. in England embarked on a project in 1910 to 
produce synthetic rubber. Since butanol was required for the process, the 
possibility of producing it via microbial fennentation was investigated. Chaim 
Weizmann, a chemist and a self-trained microbiologist, isolated a strain of 
C. acetobutylicum that could produce good yields of butanol and acetone from 
starchy substrates. C. acetobutylicum can fennent a wide variety of substrates 
including starch in the fonn of maize-mash, sugar in molasses, and other substrates 
such as Jerusalem artichokes and algal biomass. With the outbreak of the First 
World War in 1914, the demand for acetone increased. As part of the war effort, 
2(x)() pounds of acetone per week were fennented from maize at a plant owned by 
Strange and Graham Ltd. When the blockade by the Gennans affected the 
availability of maize in the United Kingdom, the process was transferred to Canada 
and the United States. 
After the war, the emphasis of the AB fennentation switched to the production of 
butanol, which was used as a solvent in nitrocellulose lacquers for the automobile 
industry. Attempts were made to maximise the profttability of the AB fennentation 
by several processes: removing the solvents, collecting the CO2 (carbon dioxide) 
for sale as compressed gas or dry ice, using the H2 (hydrogen) for the 
hydrogenation of vegetable oils and selling the residual biomass as animal feed. By 
1927, 96 fennentation plants were in operation in Illinois and 52 in Indiana, close to 
the maize-growing areas of the United States. In the 1930's molasses replaced 
maize as the substrate of choice due to low costs. With the advent of the Second 
World War came the increased demand for acetone and the AB fennentation was 
again given high priority. After 1936, plants were built in Japan, Australia, India 
and South Africa. By the end of the war, two-thirds of the butanol, and one-tenth of 
the acetone produced in the US was via AB fennentation, with the remainder being 
sythesized chemically. 
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By 1960, however, the process had ceased to be financially viable and production in 
the US and Britain had virtually stopped. The chemical synthesis of acetone (from 
propylene) and butanol (from ethylene) was a much cheaper alternative. Also, the 
increase in the price of molasses due to its incorporation into animal feed meant that 
the costs incurred were too high. In South Africa, the production of solvents via 
fermentation continued long after it had been stopped in Western countries. This 
was due to the lack of a cheap petroleum supply and the availability of cheap 
molasses. In 1982, however, the plant in Germiston, South Africa followed suit and 
closed due to economic constraints. 
The possibility of converting waste products into desirable commodities via 
fermentation seems increasingly attractive today, in the light of environmental 
awareness. Sulphite waste liquors from the paper industry and whey from the dairy 
industry can both be used as substrates by C. acetobutylicum. The bacterium can 
also be used in the biological conversion of sulphur gases. Gas synthesized from 
coal has a high sulphur content in the form of H2S (hydrogen sulphide) and COS 
(carbonyl sulphide). Extraction of the sulphur is expensive, but the cost would be 
reduced if the gas volume were decreased. The biological conversion of these gases 
would result in solvent products and would reduce the volume of the sulphur gas, 
thereby generating income. This process is possible using a 2-stage continuous 
fermentation; with the conversion of CO (carbon monoxide) to acids by 
Butyribacterium methylotrophicum and the conversion of the acids to solvents by 
C. acetobutylicum (Grethlein, 1992). 
The AB fermentation, in its heyday, ranked second in importance to the production 
of ethanol by yeast. Today, the fermentation is still important in the People's 
Republic of China where it generates half of the country's supply of butanol. 
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Although the process is not economically viable at present in the Western world, 
changes in the process technology or strain improvement by genetic engineering 
could make it financially attractive. 
Different strains of C. acetobutylicum have been identified and used in the study of 
the genetics of the bacterium including C. acetobutylicum strains ATCC 824, 
NCIMB 8052 and DSM 1731. The C. acetobutylicum strain P262, which was used 
in this study, was identified as being a good producer of solvents and was used 
industrially by National Chemical Products in Germiston, South Africa. The 
bacterium appears to differ substantially from other C. acetobutylicum strains in 
that probes made from a number of cloned C. acetobutylicum ATCC 824 genes do 
not hybridize to DNA (deoxyribonucleic acid) from the C. acetobutylicum P262 
strain (Wilkinson and Young, 1993). The genome of C. acetobutylicum P262 is 
small (2.85Mbp) in comparison to those of C. acetobutylicum strains ATCC 824 
and DSM 1731 which are 4.0 and 3.5Mbp, respectively, and strain NCIMB 8052 
which has a genome size of 6.5Mbp (Wilkinson and Young, 1993), The different 
strains have different fermentation characteristics (Young et aI., 1989a) and may 
differ in the regulation of their solvent metabolism. 
1.1.2 The biochemistry of acid and solvent production 
The biochemical pathways involved in acid and solvent production in 
C. acetobutylicum have been studied extensively during the past 20 years and are 
now well-formulated. The review by Jones and Woods (1986) has been used in 
writing this and following sections. 
The growth of C. acetobutylicum during normal batch culture is biphasic. During 
the logarithmic growth phase, known as acidogenesis, the bacterium produces 
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acetate, butyrate, H2 and CO2 from an available carbohydrate source and A TP 
(adenosine 5'-triphosphate) is generated (Fig. 1.1). 
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The production of acetic and butyric acids causes a decrease in the pH of the 
medium. These undissociated acids are thought to inhibit cell growth by 
partitioning within the membrane and acting as uncouplers, leading to a collapse of 
the pH gradient. The concentration of acids increases until a critical breakpoint pH 
is reached (Jones et ai., 1982) which varies for different strains (Jones and Woods, 
1986). For C. acetobutylicum P262, the breakpoint occurs at pH 5.2, which is 
higher than that for other strains. The decrease in the pH of the medium and an 
increase in undissociated butyric acid signal the end of the acidogenic phase. 
During the second, stationary phase of growth, known as solventogeneis, solvents 
are produced. The carbohydrate source is depleted further while the acids in the 
medium are reassimilated and the solvents, acetone, butanol and ethanol are formed 
(Fig. 1.1). The shift to solventogenesis may well be an adaptation of the bacterium 
because acid reassimilation detoxifies the environment by raising the pH level. In a 
typical batch culture, the reassimilation of butyrate and acetate is via the Co A­
transferase-acetoacetate decarboxylase pathway. Acid uptake is therefore coupled 
to acetone and CO2 production (Hartmanis et ai., 1984). During solventogenesis, 
two sets of dehydrogenases are required to reduce acetyl-CoA to ethanol and 
butyryl-CoA to butanol. Ethanol production in C. acetobutylicum is constitutive 
and is not linked to the production of acetone or butanol (Bertram et ai., 1990). The 
generation of a mutant of C. acetobutylicum by transposon mutagenesis, that 
produced ethanol but was defective in the production of acetone and butanol, 
confmned this (Babb et ai., in press). Butanol is the most toxic of the solvents 
produced. It exerts a chaotropic effect, on the cell membrane; increasing 
permeability and fluidity such that the proton motive force is dissipated 
(Terracciano and Kashket, 1986). The isolation of butanol-resistant strains of 
C. acetobutylicum, however, did not prove to be useful for increased butanol yield, 
as the concentrations of solvents obtained were similar to those obtained with 
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industrial strains (Jones, 1993). Also, a butanol-resistant mutant isolated by Baer 
(1993), only produced trace amounts of butanol showing that increased tolerance 
was not related to increased production of the solvent. 
Associated with the shift to solventogenesis, is a change in morphology (Long et 
ai., 1984). During acidogenesis, the cell is highly motile and rod-shaped. Motility 
decreases before the pH breakpoint is reached and a storage product, granulose, is 
laid down. Solventogenesis is characterised by swollen clostridial forms, that are 
cigar-shaped, and by the production of an extracellular slime layer (Jones et al., 
1982). The production of an endospore is eventually followed by the release of a 
resistant spore from the mother cell. 
The complex, branched nature of the pathways involved in acid and solvent 
formation in C. acetobutylicum enable its adaptation to different growth conditions. 
However, future industrial-scale fermentations may necessitate the channelling of 
the pathways to one or two products, in order to increase product yield and to 
become economically competitive. Therefore present research needs to address the 
mechanisms whereby the bacterium directs and responds to the carbon and electron 
flow within its pathways. 
1.1.3 Energy and electron flow 
Bacteria that grow via anaerobic fermentation are limited by the availability of 
A TP. The complexity of the branched pathways involved in energy generation and 
the generation of end products reflects the ability of anaerobes to adapt to energy 
limitation. During glycolysis in C. acetobutylicum less ATP is generated than is 
required for biosynthesis and growth, but too much NADH (reduced nicotinamide 
adenine dinucleotide) is produced. Additional A TP is generated via the production 
of acetate and butyrate. Like most anaerobic bacteria that ferment substrates, one 
9 Introduction 
of the main problems is the disposal of reducing power, either in the form of 
reduced carbon compounds (such as solvents) or in the form of hydrogen. During 
the conversion of pyruvate to acetyl-CoA, electrons are donated to the electron 
carrier, ferredoxin, which can either accept or donate electrons. The electrons are 
donated to the hydrogenase enzyme which adds them to protons to produce 
hydrogen. During acidogenesis, the hydrogenase is very active and the excess 
NADH that was produced during glycolysis is reoxidised through the 
oxidoreductase pathway resulting in increased H2 production. Some NADH is also 
used up in the generation of butyrate, which is energetically less favourable to 
produce than acetate. Towards the end of acidogenesis ATP concentrations reach a 
minimum since ATP is diverted from biosynthesis to be consumed by ATPase as 
protons are extruded across the cell membrane to maintain the pH gradient. The pH 
gradient increases and the integrity of the cell membrane is maintained. However, 
it was noted that there is a drastic increase in the concentration of NADPH (reduced 
nicotinamide adenine dinucleotide phosphate) and NADH in the cell until 
solventogenesis is induced (Grupe and Gottschalk, 1992). During solventogenesis, 
H2 and CO2 production decreases and ATP concentrations decrease due to a 
reduction in acid production. The decrease in hydrogen production in the cell, 
alters the route of electron and carbon flow (Jones and Woods, 1989). To dispose 
of reducing equivalents the cell must now redirect its carbon flow to produce 
reduced products such as solvents. The aldehyde and alcohol dehydrogenases 
require NAD(P)H for alcohol production. The excess NADH generated during 
glycolysis of glucose to pyruvate is now utilised and electrons from reduced 
ferredoxin are sequestered for the reduction of NAD or NADP by the appropriate 
ferredoxin oxidoreductase. 
The regulation of the electron flow within C. acetobutylicum has been reviewed by 

Jones and Woods (1986) and by Woods and Santangelo (1993). In short, four 
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proteins are responsible for most of the electron distribution; hydrogenase, 
ferredoxin and the NADH- and NADPH-dependent ferredoxin-oxidoreductases. 
Reduced ferredoxin can either transfer electrons via the hydrogenase to produce H2 
or via the ferredoxin-oxidoreductase to produce reduced pyrimidine nucleotides. 
It has been shown that a number of factors can induce the shift to solventogenesis. 
Firstly, reducing the pH of the medium to the breakpoint pH can induce the shift 
(Bahl et al., 1982). An increase in the intracellular concentration of undissociated 
butyric acid is also related to an induction of solventogenesis. Factors that prevent 
the hydrogenase enzyme from forming hydrogen also induce the shift. These 
factors include gassing with CO, which inhibits the hydrogenase (Kim et al., 1984), 
and adding electron carrier dyes such as methyl and benzyl viologen, that prevent 
hydrogen formation and increase butanol production (Roa and Mutharasan, 1988). 
There may be two regulators that control the metabolic switch. It has recently been 
proposed that a change in the internal ATP level induces acetone formation while 
an increase in NAD(P)H levels provides the signal to switch on butanol production 
(Grupe and Gottschalk, 1992). The changes that occur in energy and electron flow 
are complex and may form part of a regulatory signal that induces the shift from 
acidogenesis to solventogenesis. 
The onset of solventogenesis may be regulated by a number of factors: 
1]. An alternative sigma factor may direct transcription of a distinct class of 

promoters upstream of solvent genes (Petersen et al., 1993). Two heat 

shock operons, groESL and dnaK that are induced in C. acetobutylicum 

during the onset of solventogenesis, however, do not appear to be 

recognised by alternative sigma factors. Instead, an II-bp hairpin loop 
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located before the start of both operons may regulate their expression 
(Naberhaus and Bahl, 1992; Naberhaus et al., 1992). 
2]. A decrease in nucleotide levels occurs during the switch to 

solventogenesis (Santangelo et al., 1989) which may indicate a role for 

small effector molecules in the regulation of metabolic pathways. 

3]. The phosphorylation of proteins within a signal transduction pathway 

may induce the switch to solventogenesis. A heat shock protein (DnaK) 

that can phosphorylate a 50kDa protein in C. acetobutylicum may form 

part of such a pathway (Naberhaus et al., 1992). 

4]. A rare threonine tRNA (transfer RNA) gene may playa role in the 

translational control of solvent genes in C. acetobutylicum. Sauer and 

Diirre (1992) found that a C. acetobutylicum mutant, that was defective 

in acetone and butanol formation, had a transposon inserted 55-bp 

upstream of the tRNAThr gene. However, levels of the tRNAThr were 

the same during acidogenesis and solventogenesis. Therefore the 

regulation of genes by this tRNA may occur at the level of processing of 

the primary transcript of the tRNA, charging of the tRNA or by 

modification of the tRNA molecule. 

1.1.4 The cloning of genes involved in electron transfer 
In anaerobic bacteria, electrons transfer from molecules with a negative redox 
potential to molecules with a more positive redox potential. Metronidazole, a drug 
which requires reduction in order to be active against anaerobic organisms, has a 
relatively positive redox potential and can, therefore, accept electrons from 
components of the clostridial electron transfer network. It has been shown that 
metronidazole preferentially accepts electrons from ferredoxin and in turn, from the 
hydrogenase, thereby temporarily preventing the production of hydrogen in the 
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clostridia (O'Brien and Morris, 1972; Lockerby et ai., 1984; Church et ai., 1988). 
This will be discussed in detail in Section 1.2 which is devoted to metronidazole. 
The drug, therefore, has been used as a tool for the isolation of a flavodoxin 
electron transfer gene and a hydrogenase gene from C. acetobutylicum P262 
(Santangelo et ai., 1991). A number of other DNA fragments from 
C. acetobutylicum also reduced the drug, implying that they may contain electron 
transfer genes or reductive enzymes. One such fragment, cloned into pMETI0B, 
has formed the basis of the study presented in this thesis. 
1.1.S The cloning of solventogenesis genes 
Several researchers have concentrated on the cloning of solvent production genes in 
C. acetobutylicum with a view to the future manipulation of metabolic pathways to 
increase solvent yields. An NADPH-dependent alcohol dehydrogenase involved in 
ethanol and butanol production, was cloned from C. acetobutylicum P262 
(Youngleson et ai., 1989b). In addition, two butanol dehydrogenase genes were 
cloned from C. acetobutylicum ATIC 824. They were primarily NADH­
dependent, indicating that a number of enzymes carry out the conversion of 
butyraldehyde to butanol (Welch et ai., 1989; Petersen et ai., 1991). Genes 
involved in acetone formation have also been cloned: the acetoacetyl­
CoA:acetate!butyrate:CoA transferase and the acetoacetate decarboxylase (Cary et 
ai., 1990; Gerischer and Diirre, 1990; Petersen and Bennet, 1990). Other genes 
from the biochemical pathways involved in solvent formation that have been cloned 
include the thiolase (Petersen and Bennett, 1991) and the 3-hydroxybutyryl CoA 
dehydrogenase (Youngleson et ai., 1989a). Two genes responsible for butyrate 
production, the butyrate kinase and the phosphotransbutylyrase were also cloned 
(Cary et ai., 1988). 
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At present, techniques for the genetic transfonnation of C. acetobutylicum are still 
in the developmental stage. Vectors used in transfonnation are nonnally 
Escherichia coli/c. acetobutylicum or Bacillus subtilislC. acetobutylicum shuttle 
vectors which contain Clostridium replication and antibiotic resistance functions. 
The improved regeneration of protoplasts resulted in efficient transfonnation of 
protoplasts of C. acetobutylicum NI-4081 (Reysett et al., 1988). Electroporation of 
whole cells of C. acetobutylicum strain NCIMB 8052 was first demonstrated by 
Oultram et al. (1988). The cloned acetoacetate decarboxylase and 
phosphotransbutyrylase genes of C. acetobutylicum ATCC 824 have been 
successfully transformed into the homologous host by electroporation using vector 
pFNK1, a B. subtilislC. acetobutylicum shuttle (Mennelstein et al., 1992). The 
enzyme activities of these two genes were increased in C. acetobutylicum 
ATCC 824 and their effect on product fonnation is currently being investigated. 
This is the first example of the successful transfonnation of product genes back into 
C. acetobutylicum, which represents a critical step towards the future genetic 
manipulation of the bacterium to increase solvent yields. However, no successful 
electroporation of C. acetobutylicum strain P262 has been reported. Successful 
transfonnation of C. acetobutylicum has also been achieved via conjugative 
methods using broad-host-range enterococcal plasmids. Plasmids have been 
transferred to C. acetobutylicum from Enterococcus faecalis (Yu and Pearce, 1986), 
E. coli (Williams et al., 1990) and B. subtilis (Young, 1993). Conjugative 
transposons such as Tn916 from E. faecalis can also be used as a tool for the 
genetic analysis of Gram-positive organisms such as C. acetobutylicum (Young, 
1993) 
It is convenient that E. coli has proved to be an excellent heterologous host for 
cloned C. acetobutylicum genes as it facilitates the study of the genes at the 
molecular level. C. acetobutylicum DNA has a very low G+C content of 28% to 
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29% (Cummins and Johnson, 1971) and therefore, codon usage is strongly biased 
towards codons in which A and U predominate. Therefore, large differences occur 
in codon usage between E. coli and C. acetobutylicum for the amino acids arginine, 
leucine, threonine, proline, glycine and isoleucine (Young et al., 1989). Where 4 or 
6 synonymous codons are available, there is a strong preference for those codons 
that have U or A in the wobble position (third base). However, the alcohol 
dehydrogenase, endoglucanase and cellobiose genes were expressed efficiently in 
E. coli in spite of the difference in codon bias (Youngleson et al., 1988; Zappe et 
aI., 1986). Gene expression may have been aided by the presence of E. coli-like 
promoters and ribosome binding sites in the A-T rich clostridial DNA. Unlike 
C. acetobutylicum, E. coli is able to grow either aerobically or anaerobically and 
this ability has been utilised in the study presented here. 
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1.2 Metronidazole 
1.2.1 Development and use 
In 1954 the phannaceutical company, Rhone-Poulenc, decided to develop a drug 
that would be effective against the anaerobe Trichomonas vaginalis which causes 
human vaginitis. Previous therapy for this disease consisted of either vinegar 
douches (to normalise the pH of the vagina) or methyl violet impregnated tampons 
(Edwards, 1980). Azomycin, a 2-nitroimidazole, that was isolated from a 
Streptomyces was found to be active against the trichomonad. More than 200 
chemicals, related to azomycin, were synthesized and subsequently screened for 
activity. Metronidazole (l-hydroxyethyl-2-methyl-5-nitroimidazole, Flagyl@) was 
found to display the best balance between efficacy and toxicity. The frrst clinical 
trials began in France in 1958 and since then its use has become widespread (Roe, 
1977). The nitroimidazole group of drugs has a wider spectrum of activity than any 
other antimicrobial drug, encompassing a wide range of anaerobic Gram-positive 
and Gram-negative bacteria and protozoa. Today, metronidazole is still the drug of 
choice for the treatment of trichomoniasis of which approximately 150 million 
cases are reported each year (Johnson, 1993). 
Following the incredible success of the drug came observations that it was useful 
against a variety of human diseases including Giardia Lamblia. G. Lamblia was 
frrst discovered by Leeuwenhoek in 1681 in his own stools (Smith and Woolfe, 
1980). Today, it is the most common pathogenic internal parasite in the US and the 
incidence is even greater in poorer, developing countries. It can cause acute 
infection that results in diarrhoea, cramps and weight loss. Some patients become 
carriers and the disease may recur. Mild, chronic infections may go undiagnosed 
and untreated. Metronidazole is frequently prescribed for therapy and cure rates of 
86% to 91 % have been reported (Smith and Woolfe, 1980). Metronidazole is also 
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used to treat Vincent's disease, a gingivitis, which causes a painful acute ulcerative 
condition of the gums. In fact, it was the cure of Vincent's disease in a woman who 
was receiving metronidazole for the treatment of a T. vaginalis infection, that led 
to the realization that metronidazole acted specifically against obligate anaerobes 
(Shinn, 1962). The drug is also active against Entamoeba histolytica which causes 
amoebiasis, and is reported to infect 10% of the world's population (Johnson, 1993). 
Gardnerella vaginalis, which causes vaginitis is also susceptible to metronidazole, 
as is Helicobacter pylori, which is implicated in gastroduodenal ulcers (Edwards, 
1980). Nitroimidazoles are routinely used to prevent post-operative sepsis which is 
usually caused by the Gram-negative Bacteroides spp. and the Gram-positive 
Clostridium spp. Other nitroimidazoles, that are based on the heterocyclic structure 
of metronidazole, have appeared since the inception of metronidazole in the early 
1960's, (Fig. 1.2). These compounds have extended the range of activity of the 5­
nitroimidazoles to include a wider range of pathogenic microorganisms. 
Both metronidazole and misonidazole have been extensively used in cancer 
radiotherapy. When a cancerous tumour grows it tends to exclude the surrounding 
blood supply, causing the tumour cells to become hypoxic or micro-aerophilic 
(Edwards, 1980). Anticancer drugs have difficulty in penetrating the tumour due to 
lack of a good blood supply, and in addition penetrate poorly due to their large 
molecular weight. For an inoperable tumour therefore, radiotherapy is the only 
practical solution. The nitroimidazole drugs are effective for three reasons. Firstly, 
they are small molecules, and can penetrate tumour cells better than any other 
drugs. Secondly, they are relatively toxic to hypoxic cells because reduction of the 
drug occurs only in oxygen-starved environments, and thirdly, reduction of the drug 
within tumour cells creates a favourable concentration gradient which facilitates 
drug entry into tumour cells. The last two factors will be discussed in greater detail 
in Section 1.2.2. The nitroimidazoles cause strand breakage of DNA and act as 
17 Introduction 
radiosensitisers due to the synergistic effect of the DNA damage induced by the 
drug and by the radiation treatment (Edwards, 1980). 
Metronidazole 
Oimetridazole 
Tinidalole 
r)-CH, Ornilialole 
ON I 
2 CH,CH--CH CI 
I 2 
OH 
Nimorazole (nitrimidazine) 
Misonidazole 
Fig. 1.2 A range of structures of nitroimidazole drugs (Edwards, 1980). 
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Toxicity of metronidazole is low, with common side effects being a metallic taste 
and a furry tongue, for doses of less than two g (gram)s per day (Edwards, 1980). 
At higher doses of up to 10 g per day, which are required for radiosensitisation, 
nausea and vomiting can occur. Metronidazole can affect the DNA of bacteria, as 
shown by the Ames test, and it has been shown to increase the incidence of cancer 
in mice (Rustia and Shubik, 1972). Therefore there has been concern that the drug 
or its metabolites may be mutagenic or carcinogenic to humans. However, a study 
of 771 women in 1979, who were given metronidazole for the treatment of 
trichomoniasis, showed that there was no statistically significant increase in the 
incidence of cancer (Beard et ai., 1979). Obviously, the drug should be 
administered only if necessary and with caution. 
1.2.2 Mechanism of action 
Some details about the mechanism of action of metronidazole is known, but several 
questions remain unanswered - such as: what actually causes damage to the cell and 
how? It is known that reduction of the nitro group of nitroimidazoles is required in 
order to kill susceptible cells. This step is the basis for the selective cytotoxicity of 
the drug. In anaerobic bacteria and protozoa, pathways of sufficiently low redox 
potential are present, which allow for reduction of the drug, whereas, in aerobic 
cells, pathways of higher redox potential cannot reduce the drug, thereby rendering 
it inactive (Johnson, 1993). 
1.2.2.1 Entry into the cell 
Metronidazole enters the cell via passive diffusion, although the possibility of 
active transport should not be completely ruled out. It was found that large 
quantities of [ 14C]-metronidazole were quickly taken up from the growth medium 
into cells of T. vaginalis where it was rapidly metabolized (Ings et ai., 1974). The 
reduction of the drug inside the cell resulted in a decrease in the concentration of 
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the original, unchanged compound in the cell. Thus a transmembrane concentration 
gradient was established which promoted the uptake of metronidazole into the cell 
(Ings et al., 1974; Miiller, 1983), 
1.2.2.2 Reductive Activation 

Much of the following section is dealt with in a review by Edwards (1993). 

Theoretically, the reduction of a typical nitroaromatic compound would require the 

addition of six electrons (6e-) to reduce a nitro group (-N02) to an amino group (­

NH2), equation [1], (Edwards, 1993). This classical pathway includes nitro so (2e-) 
and hydroxylamino (4e-) intermediates. 
However, the energy required for such a process is too great and also the single 
electron nitro radical ion undergoes rapid degradation to form a nitrite ion (N02-) 
and an imidazole radical, equation [2], which prevents further reduction. 
[2] 
The actual process by which this short-lived ion causes cell death is unknown. 
However, it is proposed that it causes DNA damage and interacts with other cell 
components, such as proteins and membranes, leading to cell death (Edwards, 
1993), 
Reduction of metronidazole in anaerobes is thought to occur either via general 
reductive enzymes, or via electron carriers such as ferredoxin or flavodoxin 
(Edwards, 1993). A redox potential expresses, in volts, the potential for electrons 
to be donated or received in a reaction by a molecule that is 50% oxidised and 50% 
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reduced. If the reaction is only a reductive process and is not reversible, it is 
referred to as a reduction potential. All anaerobes posses redox mechanisms of 
about -43Om V to -46Om V, which includes the value for ferredoxin. Metronidazole, 
however, has a redox potential of -41SmV. A redox reaction with a lower potential 
(more negative) than metronidazole, will donate electrons to the drug. In other 
words, metronidazole with a more positive reduction potential will act 
preferentially as an electron acceptor. In aerobes, however, the lowest redox 
potentials are about -324mV, which are more positive than that for metronidazole. 
Therefore, the drug cannot accept electrons (ie. be reduced) in aerobic organisms 
and is therefore inactive. 
Even if reduction happened to occur in the presence of oxygen, damage would be 
minimal due to a reaction known as "futile cycling". Basically, since oxygen is the 
best electron acceptor in any biological system, it would abstract an electron from 
the nitro radical anion, forming the inert metronidazole compound and a superoxide 
(Edwards, 1993). A schematic diagram of all the reactions involved in 
metronidazole reduction in the cell is presented in Fig. 1.3. 
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Fig. 1.3 The mechanism of action of nitroimidazoles (Edwards, 1993). 
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1.2.2.2.1 Reduction via the electron transfer system 
It is thought that the reductive activation of metronidazole can occur via reduced 
electron-transport proteins in C. acetobutylicum and in other anaerobes. These 
proteins are normally involved in the oxidative fermentation of pyruvate, that is, in 
carbohydrate metabolism. 
The frrst indication that metronidazole may be reduced via such a system was 
reported by Edwards and Mathison (1970), who noted that the addition of 
metronidazole to a culture of T. vaginalis inhibited hydrogen production. O'Brien 
and Morris (1972) also showed the same effect in cell extracts from 
C. acetobutylicum, while no effect on carbon dioxide production or acetyl­
phosphate production was observed. 
It was demonstrated in vitro, using T. vaginalis extracts, that metronidazole could 
be reduced by ferredoxin (Lindmark and Milller, 1976). The reduction of 
metronidazole by ferredoxin was also shown to occur in cell free extracts of 
Clostridium pasteurianum (Lockerby et al., 1984). The hydrogenase enzyme was 
also found to indirectly reduce metronidazole (Church et al., 1988). Purified 
hydrogenase I from C. pasteurianum caused reduction of metronidazole when 
coupled with electron carriers such as ferredoxin or the low redox potential electron 
carrier dyes such as methyl viologen. A flavodoxin from C. acetobutylicum was 
isolated and characterised based on its ability to activate metronidazole (Santangelo 
et al., 1991). Flavodoxin is a low redox potential protein which can replace 
ferredoxin as an electron carrier. 
The enzyme pyruvate ferredoxin oxidoreductase (PFOR) has also been implicated 
in the susceptibility of bacteria to metronidazole. Britz and Wilkinson (1979) found 
that metronidazole-resistant mutants of Bacteroides JragiUs had decreased levels of 
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PFOR. Similarly, PFOR activity was not detected in cell extracts of metronidazole­
resistant Clostridium perfringens (Sindar et al., 1982). The presence of 
metronidazole susceptibility amongst anaerobes was also found to correlate to the 
activity of the PFOR enzyme (Narikawa, 1986). 
Thus metronidazole acts as a type of "electron sink" drawing electrons away from 
the electron transport system components; directly from ferredoxin or PFOR, or 
indirectly from hydrogenase. Initially it was thought that the electron depletion, 
that resulted in the inhibition of various pathways, was the key to the mechanism of 
action of metronidazole (Edwards and Mathison, 1970). However, the interruption 
of electron flow by metronidazole cannot explain the immediate bactericidal effect 
of the drug (Church et al., 1991), nor the resumption of hydrogen production after 
the reduction of all the metronidazole present (O'Brien and Morris, 1972). A later 
study, however, speculates that the drop in hydrogen production would not be so 
marked if the electron transport pathway is saturated at the time of drug addition 
(Lloyd and Kristensen, 1985). The authors suggest that a reduction product of 
metronidazole - perhaps the nitro radical anion - may directly damage some part of 
the electron transport pathway between pyruvate and hydrogenase. Whatever the 
case, it appears that a reduction product of metronidazole causes cell death. 
1.2.2.2.2 Other forms of reduction 
Other enzymes, that do not constitute part of the electron transfer system have been 
implicated in the reduction of the nitro group of metronidazole. These enzymes 
have broadly been referred to as nitroreductases (Chrystal et al., 1980). 
McLafferty et al. (1982) thought that sensitivity to metronidazole was due to the 
rate of reduction of the nitro group. Similarly, enzymes in E. coli that are involved 
in the reduction of nitrates and chlorates were found to be responsible for reducing 
metronidazole to its active form (Yeung et al., 1984). The same study showed that 
23 Introduction 
mutant E. coli strains with reduced ability to repair DNA (due to recA and uvr 
lesions) were more susceptible to metronidazole. It appears that bacterial 
susceptibility to metronidazole may not only be related to the generation of a 
reactive reduction product that is cytotoxic, but is also due to the inherent 
sensitivity of the bacterium to the reactive product. 
The authors proposed a model: metronidazole (M) is reduced to form a labile, 
active product (M*) which can cause damage. Only when the rate of damage 
exceeds the rate of DNA repair, will it result in a lethal event. Thus two 
mechanisms of susceptibility to metronidazole exist, one involving an efficient 
reductase and the second involving an impaired DNA repair system. 
It was initially thought that facultative anaerobes, such as E. coli, were not 
susceptible to metronidazole. However, Prince et al. (1969) first noted that under 
anaerobic conditions, E. coli was affected by the drug. ArecA E. coli strain, that 
was impaired in its DNA repair capacity and susceptible to metronidazole, was 
mutated for its nitrate reductase, making it slightly less susceptible under anaerobic 
conditions (Santangelo et ai., 1991). This E. coli mutant F19 was considered a 
suitable host for the negative selection of genes that reduced metronidazole and 
caused cell death. 
1.2.2.3 Toxic effects of metronidazole 
Metronidazole is relatively inert and nontoxic (MUller, 1983). However, the 
reduction of the drug, as discussed in the previous section leads to the production of 
labile, cytotoxic intermediates that cause cellular damage. 
There has been some speculation as to how metronidazole interacts with DNA to 
cause damage. The frrst indication that metronidazole targeted DNA, showed that 
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the drug inhibited the incorporation of [14C]-labelled nucleotides into DNA and 
RNA in T. vaginalist ie. it inhibited nucleic acid synthesis. Plant and Edwards 
(1976) also showed that metronidazole inhibited DNA synthesiSt but that RNA 
synthesis was unaffected. They proposed that nitroimidazoles degraded DNA by a 
process of strand breakage. 
Binding of metronidazole to DNA does not occur if the drug is unreduced (LaRusso 
et al. t 1977). Other binding studies have failed to show that significant amounts of 
metronidazole bind to DNA (Malliaros and Goldmant 1991). In factt only a 
maximum of 3 molecules of metronidazole per HXJO-bp of DNA have been shown 
to bind (Knox et al., 1981). Binding was in proportion to the ionic strength of the 
buffer indicating that electrostatic charges are probably involved in the process. It 
is now known that the amount of damage nitroimidazoles cause, is related to the 
A+ T content of the DNA. Therefore, damage is not due to random strand breakaget 
but rather involves cleavage at specific targets in the DNA (Rowley et al. t 1980). 
Misonidazolet a nitroimidazole, has been shown to specifically cleave thymidine 
phosphates from DNA. In additiont uridine residues were cleaved and released 
from RNA indicating that the nucleotide base T is the target, and not the sugar 
backbone of the DNA (Knox et al. t 1981). The relationship between DNA damage 
and A+ T content is an additional factor therefore in the selective toxicity of 
nitroimidazoles. Pathogenic anaerobes that are susceptible to nitroimidazoles have 
high A+T contents (Trichomonas has 71 %t Clostridium has 73%) whereas non­
susceptible organisms have low A+ T contents (Rhodospirillum has 38%). 
It is thought that the one electron nitro radical ion causes DNA damage (Tocher and 
Edwards, 1990). The nitro ion becomes protonated and probably takes electrons 
from DNA, thus oxidising it and causing strand breaks (Edwards, 1993). A 
proposed mechanism of action of metronidazolet including the oxidative damage 
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step, is represented diagrammatically in Fig. 1.3. The disproportionation reaction 
occurs at high rates of reduction and basically "disables" two protonated radicals, 
causing a reduction in the amount of DNA damage (Zahoor et al., 1987). In the 
process of abstracting electrons from DNA, the nitroimidazole (in this case 
misonidazole) reacts directly with the DNA and oxygen is transferred from the nitro 
group of the misonidazole radical to the DNA sugar damage product (Kappen et 
al., 1989). 
Other forms of damage due to metronidazole have been observed. Ninety-nine 
percent of C. pasteurianum cells were killed within five minutes of drug addition 
at 10mg!l. However, the cytotoxicity of the reductive products of metronidazole 
cannot account for such rapid killing. Therefore the authors proposed that cellular 
lysis may be triggered on metronidazole addition (Church et al., 1991). Levett 
(1991) also showed that rapid killing of vegetative Clostridium difficile cells 
occurred over a wide range of metronidazole concentrations greater than the 
minimum inhibitory concentration. 
Metronidazole may also alter the surface properties of bacteria. Metronidazole 
decreased the cell surface charge of B. Jragi/is and made the cell surface 
hydrophobic, which may facilitate the engulfment of the cell by phagocytes 
(Cavalcanti et al., 1991). Also, the cells became filamentous and showed a 
significant loss of cytoplasm. Elongation of E. coli upon addition of 
metronidazole has also been observed (Jackson et al., 1984). DNA damage in the 
cell would lead to the activation of the DNA repair genes. The SOS repair system 
has approximately 20 genes associated with it and it is known that nitroimidazoles 
induce DNA repair (Widdick and Edwards, 1991). DNA repair mutants that are 
susceptible to UV (ultraviolet) light, are also susceptible to metronidazole, which 
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suggests that both agents cause similar lesions in bacterial DNA (Yeung et ai., 
1984). 
1.2.2.4 End products 
Nontoxic end products such as acetamide and 2-hydroxyethyl oxamic acid are 
formed following the reduction of metronidazole. These innocuous end products 
diffuse out of the cell. An additional advantage of the drug, therefore is that the 
reactive and toxic species are generated inside the cell, which may reduce its 
toxicity to humans. 
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1.3 Transfer RNA 
The translation of the nucleotide sequence of a gene into the amino acid sequence 
of a protein is one of the most fundamental processes in living cells. tRNA 
(transfer RNA) links the two sequences by adapting the nucleotide triplets of a 
DNA sequence into a sequential aa (amino acid) sequence. Firstly, the tRNA is 
required to interact specifically with an aminoacyl-tRNA synthetase that charges 
the tRNA with its cognate aa. Secondly, a specific interaction in the ribosome is 
required, where the anticodon interacts with the codon triplets of the mRNA at one 
end, and the amino acids are incorporated into the growing polypeptide chain at the 
other end, during translation. Detailed information on all aspects of tRNAs and 
translation are included in Watson et al., (1987) and Lewin, (1987). Therefore only 
background and details that are relevant to the discovery of two tRNA genes on 
plasmid pMETI0B (Section 3.3.1) are included in this Section. 
1.3.1 Structure oftRNA 
Transfer RNAs comprise a family of structurally similar molecules. This is because 
they must all be able to fit into the A, P and E sites of the ribosome and must be 
able to be recognised by the appropriate translation factors. However, groups of 
tRNAs that are charged with the same aa (synonymous tRNAs) must be recognised 
as being different from other groups so that the aminoacylation step can be 
absolutely specific. 
The primary sequences of hundreds of tRNA genes and tRNA molecules are now 
known from DNA and RNA sequencing information (Sprinzl et al., 1989). Most 
tRNA sequences can be depicted as a cloverleaf structure (Fig. 1.4) which is 
maintained by base-pairing between complementary sequences in the stems. The 
four arms are named according to their functions (Lewin, 1987). The acceptor arm 
normally ends in the unpaired sequence -CCA which becomes aminoacylated. The 
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D ann contains the modified base dihydrouridine (V) and the anticodon ann 
contains the anticodon triplet in the centre of the anticodon loop. tRNAs are 
classed into 2 groups on the basis of an extra ann which is a variable loop: Class I 
tRNAs include all molecules with a short extra ann of 4 to 5 nucleotides and 
represent about 75% of all tRNAs (Lewin, 1987), while Class II tRNAs constitute a 
smaller group of molecules with a larger variable loop of 13 to 21 nucleotides. 
Some mitochondrial tRNAs, however, do not follow the cloverleaf form and have 
unusual structures due to the lack of the D or T\vC anns. 
T~a(m 
0·",.. 0 E.<t....rm 
Anttcodon arm e @ 
Fig. 1.4 The typical cloverleaf structure of a tRNA molecule. From Lewin (1987). 
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In E. coli, all the tRNA genes sequenced thus far (31 genes) encode the 3' -CCA 
terminus. In the Gram-positive B. subtilis, however, 24% of the tRNA genes 
sequenced do not encode the -CCA tenninus (Komine et al., 1990; VoId, 1985). 
Most of the clusters of tRNAs found in B. subtilis contain a tRNA gene that lacks 
the -CCA, but the same gene may encode the terminus when it occurs elsewhere on 
the chromosome, in another cluster. It is not yet clear if tRNA genes lacking the ­
CCA end can be expressed as functional molecules, but it is thought that the 
terminus can be added post-transcriptionally (VoId, 1985). 
1.3.2 The chromosomal distribution of tRNA genes 
An exhaustive survey of tRNA genes on the E. coli K12 chromosome was 
undertaken due to the availability of an ordered clone library of the whole E. coli 
genome (Komine et al., 1990). Seventy-nine tRNA genes were identified by 
fingerprinting analyses of which 31 were sequenced at the DNA level. A 
comprehensive map of the tRNA genes on the E. coli chromosome indicated that 
the genes are scattered over the entire genome in 40 different transcription units. A 
maximum of 7 tRN A genes were contained in one such unit (Komine et al., 1990). 
The tRNA gene organisation in B. subtilis differs from that found in E. coli, 
because the genes are clustered in large transcriptional units and are closely linked 
to rRNA (ribosomal RNA) operons. Until gene organisation in other prokaryotes is 
investigated one can only speculate as to whether this type of organisation is typical 
of Gram-positive organisms or specific for B. subtilis (VoId, 1985). Ten EcoRI 
fragments of the B. subtilis chromosome were shown to hybridize to labelled tRNA 
(Wawrousek and Hansen, 1983). Seven of these fragments containing tRNA gene 
clusters have been sequenced and they have been found to contain a minimum of 2 
or a maximum of 21 tRNA genes in each cluster. All but one are associated with 
rRNA operons and are named after the preceding rRNA gene set (Void, 1985). 
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One cluster of 4 tRNA genes (trnY) is not associated with rRNA genes (Yamada et 
al., 1983). At least two other EcoRI fragments that are unmapped contain at least 7 
tRNA genes, but no rRNA genes (Rudner et al., 1993). 
In both E. coli and B. subtilis, many of the tRNA genes are represented more than 
once. This duplication of genes may occur in different operons, as in B. subtilis, or 
in the same operon, as in E. coli. It appears that the gene copy number for a single 
tRNA species does not exceed four (Komine et al., 1990). Pseudomonas 
aeruginosa also contains duplicate copies of the same tRNA gene in one operon 
(Bally et al., 1993). 
It had been suggested that multiple copies of tRNA genes may be necessary to 
maintain the correct amount of tRNA in a cell. However, the differences in gene 
copy number between major and minor tRNA species cannot account for the large 
differences observed in the abundance of major and minor tRNAs (Emillson et al., 
1993). The location of tRNA genes relative to the oriC was thought to affect the 
tRNA gene dosage because the chromosomal location of rRNA operons has been 
shown to cause their differential expression (Condon et al., 1992). tRNA genes that 
were close to the oriC and replicated early, therefore, would have an increased copy 
number relative to late genes. Although some tRNAs that recognise major codons 
are situated near the oriC (Komine et al., 1990), others were found to be located on 
the opposite side of the chromosome (Emillson et al., 1993). Therefore gene 
dosage effects and chromosomal location do not seem to affect tRNA abundance. 
Amino acids that are represented by more than one synonymous codon are not 
represented by all the codons equally. Instead a coding bias operates in most 
organisms. It is known that in highly expressed genes there is a bias towards the 
selection of major codons which may be as much as loo-fold higher than the 
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selection of other minor codons (Andersson and Kurland, 1990). Experiments have 
revealed that the occurrence of major codons in E. coli mRNA (messenger RNA) is 
related to the relative abundance of their cognate tRNAs (Ikemura et al., 1981). 
This bias in codon usage and in the tRNA profile of synonymous codons is thought 
to maximize growth rates by the efficient translation of the mRNA. Evolution 
would select for the use of major codons in rapidly expressed genes, but not for 
major codons in genes expressed at lower levels, thus causing the appearance of 
minor codons. In E. coli, the accumulation of tRNA species was tested. In 
accordance with the growth rate theory, tRNAs for major codons increased in 
abundance as the growth rate increased. Three minor tRNAs, however, did not 
obey the rules: they also increased in abundance as the growth rate increased 
(Emillson et al., 1993). Either the proposed model is incorrect, or perhaps the 
tRNAs may be involved in processes other than translation, for example, in 
regulation. 
1.3.3 Transfer RNAs and development 
In a number of cases it has been proposed that a particular tRNA may playa role in 
the regulation of development of certain bacteria. This will now be discussed with 
reference to Streptomyces coelicolor and C. acetobutylicum. Lastly, the possible 
role of tRNAs in the differentiation of B. subtilis will be discussed. 
In S. coelicolor, bldA mutants are defective in antibiotic production and in the 
development of aerial hyphae and spores, while being unimpaired in vegetative 
growth (Lawlor et al., 1987). Five bldA mutations were all found to be due to 
single base changes within a tRNALeu ITA that possesses the anticodon UAA. 
Streptomyces spp. have an unusually high G+C base composition (typically 73%) 
and therefore, this codon is rare in Streptomyces genes. Its rarity is biased though, 
as most of the genes that contain this codon specify regulatory or resistance proteins 
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associated with antibiotic production (Leskiw et al., 1991). It has been shown that 
processing of this primary tRNA transcript in young cultures is inefficient, but that 
processed tRNALeu TTA's increase in abundance as the culture aged (Leskiw et al., 
1993). This temporal regulation of tRNALeu TTA may point to a regulatory role for 
the molecule in differentiation and antibiotic production. 
An analagous situation has been described for a tRNAThr ACG in C. acetobutylicum 
(Sauer and Diirre, 1992). A transposon-induced insertion near this tRNA gene 
resulted in a mutant defective in acetone and butanol formation. Solvent production 
in C. acetobutylicum, like antibiotic production in Streptomyces, is associated with 
the onset of secondary metabolism and is strictly regulated. The ACG codon is also 
rare and is found exclusively in genes expressed at the end of the exponential 
growth phase, or in genes involved in the uptake and metabolism of alternative or 
minor nitrogen and carbon sources (Sauer and Diirre, 1992). However, levels of 
tRNAThr ACG during acidogenesis and solventogenesis were not found to be 
different. But, the authors proposed that if temporal regulation of the processing of 
the primary transcript occurred, it may provide a mechanism whereby this rare 
tRNA may induce a switch to solventogenesis. 
In B. subtilis, sporulation represents a second stage in the cellular development of 
the bacterium. It has been suggested that tRNA gene clustering in B. subtilis might 
be related to the role tRNAs play in development (Rudner et al., 1993). During 
spore germination and outgrowth, large amounts of tRNA and rRNA are needed 
due to the rapid activation of the translation machinery. The clustering of the genes 
may enable their coordinate transcription and processing. The regulatory role that 
tRNAs may play in the sporulation process has also been investigated. Conflicting 
reports as to whether the amounts of certain tRNAs change during the different 
stages of development, have been published (VoId, 1985; Henner and Steinberg, 
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1979). Rather, it is thought that the alteration might be at the level of post­
transciptional modification of the anticodon loop (Void, 1978). Therefore, in 
S. coelicoior, C. acetobutylicum and B. subtilis, tRNAs may play a role in 
regulating the onset of sporulation and secondary metabolism. 
1.3.4 Other functions for tRNAs 
Other functions for tRNAs have also been described. In E. coli, a serine tRNA has 
been shown to be involved either in the biosynthesis of certain proteins, or in the 
regulation of cell division (Tamura et ai., 1984). In E. coli, tRNAs are also known 
to be involved in regulating the expression of the trp, his, phe and ilvGMEDA 
biosynthetic operons (Landick and Yanofsky, 1987). In the trp operon, charged 
tRNATrp acts as an effector molecule that signals the presence of adequate supplies 
of a particular aa. However, when a ribosome pauses at one of two tryptophan 
codons in the mRNA leader peptide coding region, due to the low availability of 
charged tRNATrp, a transcription anti terminator is formed and the biosynthetic 
operon is transcribed. In B. subtilis, tRNA sythetase genes are regulated by a 
common transcription antitermination mechanism (Grundy and Henkin, 1993). 
Yet, each gene responds individually to the low availability of the cognate aa. The 
authors propose that uncharged tRNATyr acts as a positive regulator for the 
transcription of tyrS, the tyrosyl-tRNA synthetase gene. The uncharged tRNA 
could interact with the leader mRNA, which contains one tyrosine codon. This 
interaction could alter the terminator and cause readtbrough of the tyrS gene. 
Therefore, both charged and uncharged tRNAs have been shown to act as effector 
molecules that affect transcription by interaction with mRNA. 
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1.4 Aims and overview of this thesis 
C. acetobutylicum P262 is an industrially important bacterium that has been used in 
the past for the production of solvents via the fermentation of molasses. During the 
past 30 years in Europe and in the US and during the last 10 years in South Africa, 
no industrial fermentation of solvents using C. acetobutylicum has taken place due 
to economic constraints. However, the future genetic manipulation of genes that 
may be involved in solvent metabolism in C. acetobutylicum may improve the 
commercial viability of the process by increasing solvent yields. To this end, a 
system using the drug metronidazole was developed for the cloning of 
C. acetobutylicum electron transport genes that may play a role in its solvent­
producing pathways. This was based on the observation that the electron 
distribution and flow in the cell is largely mediated by electron transport genes 
which also largely control the carbon flow ie. the ratios of the different end­
products produced by the branched fermentation pathways. The aim of the study 
reported in this thesis was to characterize pMETIOB, a clone containing 
C. acetobutylicum P262 DNA, which conferred a metronidazole sensitivity 
phenotype on an E. coli mutant strain, in the hope of identifying genes involved in 
the electron transport pathways. The theory behind the cloning system using 
metronidazole as a tool, involved the reduction of metronidazole by electron 
transport genes encoded by recombinant C. acetobutylicum P262 DNA, thus 
causing sensitivity of the host E. coli to the reduced, toxic intermediates of the drug. 
The proposed strategy of this thesis involved subcloning of pMETIOB and protein 
and physiological studies of pMETIOB in an attempt to identify the region 
responsible for the metronidazole sensitivity. Exonuclease III shortening of DNA 
constructs would enable the precise location of the metronidazole sensitivity region 
responsible for the phenotype. Nucleotide sequencing would enable the further 
characterization of the metronidazole sensitive area and may reveal elements 
responsible for the phenotype. 
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Chapter Two 
The molecular characterization of plasmid pMETIOB 
2.1 Introduction 
The drug metronidazole has been used as a tool for the isolation of electron 
transport genes that may influence the production of solvents in C. acetobutylicum 
(Santangelo et al., 1991). Metronidazole (Flagyl®) is active against a wide range 
of anaerobic organisms and is thought to exert its effect via the reduction of its nitro 
group resulting in an activated, cytotoxic compound (Edwards, 1993). 
Metronidazole is also active against the facultative anaerobe, E. coli, and is 
especially toxic to those strains that are mutated in their DNA repair capacity 
(Yeung et al., 1984). Escherichia coli CCll8, a recA strain, was mutated via 
transposon mutagenesis to be more resistant to metronidazole (Santangelo et al., 
1991). This E. coli F19 mutant was thought to be more resistant to metronidazole 
due to a decrease in its nitroreductase activity which would result in decreased 
concentrations of the reduced, cytotoxic drug inside the bacterium. The mutant was 
considered to be a suitable host for the cloning of electron transfer genes which 
would theoretically reduce and activate metronidazole, rendering the mutant more 
sensitive to the drug. Twenty-five recombinant plasmids that contained 
C. acetobutylicum P262 DNA cloned into pEcoR251 were found to make E. coli 
F19 sensitive to metronidazole under anaerobic conditions, presumably due to the 
reductive ability of the C. acetobutylicum insert DNA. One such clone, pMET13A, 
was found to encode a flavodoxin gene and a hydrogenase gene, both of which are 
involved in electron transfer systems in C. acetobutylicum (Santangelo et al., 1991). 
A second clone, pMETI0B, was therefore characterized in the hope of identifying 
further such genes. Metronidazole sensitivity assays using the E. coli mutant F19 
were used to localize the region responsible for the metronidazole sensitivity 
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phenotype on different subclones and exonuclease III-shortened clones. DNA 
hybridization and protein analysis were also carried out to further characterize the 
clone. 
2.2 Materials and methods 
Standard materials and methods are recorded and referenced in the Appendix. All 
restriction enzymes were obtained from Boehringer Mannheim (South Africa), 
Johannesburg, except for ApoI which was obtained from New England Biolabs, 
Beverly, Massachusetts. 
2.1.1 Bacterial strains and plasmids 
Clostridium acetobutylicum strain P262 has been described by Allcock et al. (1982) 
and was used for industrial fermentation by National Chemical Products, 
Germiston, South Africa. E. coli strains used for all manipulations and for 
metronidazole sensitivity tests are presented in Table 2.1. Plasmid pMETI0B 
contains C. acetobutylicum P262 DNA cloned into the BglII restriction 
endonuclease site of the cloning vector pEcoR2S1 (Fig. 2.1 A) and was obtained 
from J. Santangelo (Santangelo et al., 1991). The plasmids Bluescript pKS and 
pSK (Stratagene, San Diego, California) were used for exonuclease III shortening 
and nucleotide sequencing (Section 3.3.1). The plasmids contain a large polylinker 
with 26 unique restriction enzyme recognition sites in the N -terminal portion of the 
lacz gene (Bluescript Instruction Manual, Stratagene). Insertion into the lacz gene 
results in a white E. coli colony, while no insertion into the polylinker enables the 
normal production of the N-terminal LacZ polypeptide, which complements the 
LacUM1S polypeptide produced from the appropriate bacterial strain resulting in a 
blue colony when plated on YT plates containing X-gal (Appendix). The 
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polylinker in these vectors also consists of unique 3' restriction sites on the outside 
edge of the polylinker and unique 5' sites and blunt sites internally. This enables 
the generation of nested deletions of the insert DNA following exonuclease ill 
treatment of digested plasmid DNA, as discussed in Section 2.2.2. 
E. coli strain Genotype 	 Reference or Origin 
JMlO5 	 thi, ppsL, endA, sbcB15 Yanish-Perron et al., 1985 
hspR4, ~(lac-proAB) 
[F', traD36, proAB, lacICJZAM15] 
JMlO9 	 recAl, endAl, gyrA96, thi, hsdR17 Yanish-Perron et al., 1985 
supE44, reLAl, A;, ~(lac-proAB) 
[F', traD36, proAB, laclCJZAM15] 
AB1157 rac', ara, argE, ~(gpt-proA)62, galK, ATCC29055 
hisG, kdgK, lacYl, leuB6, mgl5l, mtll 
qsr, rjbDl, rpsL, supE44, thil, thrl 
tsx33 , xyl5 
CCl18 	 recAl, araD139, ~(ara-Ieu)7697 Manoil and Beckwith, 1985 
~lacX74, galE, galK, thi, rpsE 
rpoB, argEam 
F19 	 ntr, phoA de120, otherwise as CCl18 Santangelo et al., 1991 
Table 2.1 E. coli strains used in this study 
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The plasmids, pKS and pSK, also contain a T7 promoter which can be used for in 
vivo transcription/translation of the cloned insert DNA (see Section 2.2.4.2). 
Plasmid pGPI-2, used in the T7 RNA polymerase expression system was a gift 
from G.U. Dachs (Microbiology Dept., UCT). 
2.2.2 DNA manipulation of pMETIOB 

Plasmid DNA was routinely prepared by the alkali-hydrolysis method of Ish­

Horowicz and Burke (1981). Both small-scale isolation (mini prep ) and large-scale 

isolation (maxiprep) of DNA are detailed in the Appendix. A 1.86kb HindIIVPstI 

C. acetobutylicum restriction DNA fragment from pMET10B was subcloned into 

the HindIIVPstI restriction endonuclease sites of Bluescript pKS and pSK (Fig. 2.1 

B). These subclones were subsequently shortened using restriction exonuclease III 

according to the method of Henikoff (1984). Subclones were digested to 

completion with endonuclease Sad that generates a 3' overhang which is not 

susceptible to the enzyme exonuclease III, and endonuclease Bamffi that generates 

a 5' overhang which is susceptible to digestion by the enzyme. Exonuclease III 

digestion produced a range of unidirectionally-shOltened nested deletions for 

phenotype testing and nucleotide sequencing (Fig. 2.1 C). 

2.2.3 Metronidazole sensitivity assays 

An aerobically grown overnight culture of E. coli F19 or E. coli CC 118 was diluted 

to approximately 103 to 104 cells per ml in sterile water. Subsequent steps were 

performed in an anaerobic glove box (Fonna Scientific Inc., Marietta, Ohio) under 

stringent anaerobic conditions in an oxygen-free atmosphere of N2, CO2 and H2 

(85 : 10 : 5). Aliquots of 100MI of the dilutions were plated onto prereduced YT 

(yeast tryptone) plates (Sambrook et ai., 1989) containing 0.2% (w/v) NaN03 and 
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0.10/0 (w/v) glucose, 100~g/ml ampicillin and different concentrations of 
metronidazole. The plates were then incubated anaerobically at 34°C for 2 days 
and the MIC (minimum inhibitOlY concentration) of metronidazole was determined. 
The MIC was defined as the lowest concentration of metronidazole (~g/ml) that 
completely inhibited growth of E. coli after 2 days at 34°C. 
2.2.4 Protein analysis 
2.2.4.1 Cell-free coupled transcription-translation system 
The Promega prokaryotic DNA-directed translation kit (No. L4500) was used 
according to the manufacturer's instmctions. Plasmid DNA from a range of 
exonuclease III-shortened clones was used in an attempt to correlate protein 
expression with the metronidazole sensitivity phenotype observed. [35S]­
methionine-labelled proteins were separated on a discontinuous SDS-page system 
(Laemmli, 1970) and viewed by autoradiography. 
2.2.4.2 T7 RNA polymerase expression system 
The method was adapted from Tabor and Richardson (1985) and Scholz et al. 
(1989). Two compatible plasmids were used in this expression system. The first 
plasmid was the kanamycin-resistant pGP 1-2 which expressed the T7 RNA 
polymerase under the control of the inducible 'APL promoter and the heat sensitive 
cI857 repressor. The second plasmid, Bluescript pSK or pKS, contained the cloned 
insert to be expressed under control of the T7 RNA polymerase promoter. 
Exclusive expression of the insert occurred after heat induction of the T7 RNA 
polymerase, while transcription by the E. coli RNA polymerase was shut off by the 
addition of rifampicin. [35S]-methionine was used to pulse-label the plasmid­
encoded proteins. Strains E. coli F19 or CCl18 were not suitable for this 
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experiment since they are rpoB (or rij), (Bachman, 1987) and therefore their RNA 
polymerase cannot be shut down by the addition of rifampicin. E. coli AB 1157, 
however, is sensitive to rifampicin and was therefore suitable. Experimental details 
are contained in the Appendix. 
2.2.5 Growth curve analysis 
A standard growth curve was detennined for E. coli JM 105 transfonned with an 
exonuclease III-shortened clone (PKS2) that displayed the metronidazole sensitivity 
phenotype in E. coli F19, compared to a clone with larger deletions (PKS4) that had 
lost the ability to make E. coli F 19 sensitive to metronidazole. This was in order to 
confum that the observed sensitivity was not due to a growth deficiency that the 
insert DNA had conferred on E. coli. The growth of these E. coli strains in LB 
(Luria-Bertani broth), (Sambrook et al., 1989) containing ampicillin (100 Jlglml) 
was monitored over an II h period. At time intervals, the OD600 was recorded and 
diluted cells were plated onto YT agar containing 100 I1g/ml ampicillin. Results 
generated are the average of three such experiments. 
2.2.6 DNA hybridization 
In order to confum the origin of the C. acetobutylicum P262 insert DNA of clone 
pMET lOB, DNA hybridization was perfonned according to Southern (1975). 
Chromosomal DNA from E. coli JM I 05 and C. acetobutylicum P262 were a gift 
from F. Lin (Department of Microbiology, UCT). The C. acetobutylicum P262 
chromosomal DNA was prepared according to the method of Zappe et al. (1986) 
which compensates for the large amount of nucleases produced by the bacterium. 
E. coli JM105 chromosomal DNA was prepared according to standard methods 
(Sambrook et al., 1989). All DNA was digested to completion with the appropriate 
restriction endonucleases. The DNA fragments were separated on a 0.8% agarose 
42Chapter Two 
gel and transferred by capillary blotting onto Hybond N+ (Amersham International, 
Amersham, UK) according to the manufacturer's instructions. 
The C. acetobutylicum P262 insert DNA of pKS 1, was purified by restriction 
endonuclease digestion, gel electrophoresis, electroelution of the DNA fragment and 
phenol-cleaning, to prepare it for use as a probe. The DNA fragment was non­
radioactively labelled with digoxigenin using the random-priming method. DNA 
labelling and hybridization were according to the manufacturer's instructions that 
accompanied the Nonradioactive DNA Labelling and Detection Kit (No. 1093 657, 
Boehringer Mannheim (South Africa), Johannesburg). Detection of the hybridized 
probe was via chemiluminescence using the AMPPD® substrate (No. 1357 328, 
Boehringer Mannheim (SA)). All practical details conceming nonradioactive 
hybridization are contained in the Appendix. 
2.3 Results 
2.3.1 DNA manipulation of pI\fETI0B 
Subcloning of the C. acetobutylicum P262 inselt DNA from pMETlOB into Bluescript 
pKS and pSK was required for nucleotide sequencing. Initial attempts at subcloning 
were unsuccessful; for instance, subcloning the entire 2.56kb BgllIlBgllI insert into the 
Bamffi restriction endonuclease site of Bluescript pKS resulted in a subclone that had 
lost the metronidazole sensitivity phenotype as determined by metronidazole 
sensitivity assays. Restriction endonuclease digestion and gel electrophoresis of this 
subclone showed that the C. acetobutylicum P262 insert DNA had one of two StyI 
restriction endonuclease sites deleted and the insert DNA deleted by 100-bp. The 
rearrangement of the insert DNA was thought to be related to the loss of the 
metronidazole sensitivity phenotype. However, a 1.86kb HindIIIlPstI restriction 
endonuclease fragment of C. acetobutylicum P262 insert DNA from pMETlOB was 
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stably subcloned into the HindIlllPstI restriction sites of Bluescript pKS and pSK to 
yield subclones pKSIOB and pSKIOB, respectively (Fig. 2.1 A and B). Both 
subclones rendered E. coli FI9 sensitive to metronidazole (see Section 2.3.2). 
These subclones were shortened using exonuclease III to generate a range of nested 
deletions, some of which were used in metronidazole sensitivity tests and for 
nucleotide sequencing (Fig. 2.1 C). 
2.3.2 Metronidazole sensitivity assays 
Metronidazole sensitivity assays were routinely performed to test the metronidazole 
MIC (minimum inhibitory concentration) of E. coli FI9 transformed with the 
various DNA constructs. Results were recorded as the average of at least three 
experiments. The MIC, under conditions of anaerobic respiration, for strain E. coli 
FI9 was previously shown to be 35 Jlg/ml, while the MIC of strain E. coli CC1l8 
was 20 Jlg/ml (Santangelo et ai., 1991). E. coli FI9 showed an increase in 
sensitivity to metronidazole (MIC =15 Jlg/ml) when transformed with pKSIOB and 
pSKIOB, compared to a control pKS plasmid (MIC =35 Jlg/ml). This indicated 
that the C. acetobutylicum P262 locus responsible for the phenotype had been 
subcloned into another vector without any loss of activity. Exonuclease llI­
shortened clones of pKSIOB and pSKIOB were also tested for their ability to render 
E. coli FI9 sensitive to metronidazole (Fig. 2.1 C). Exonuclease Ill-shortened 
clones of the pKS I OB subclone (pKS 1 to pKS5) showed a concomitant loss of 
activity as the insert DNA was progressively deleted. Exonuclease llI-shortened 
clones of the pSKIOB subclone (pSKI to pSK4) showed a partial loss of activity on 
progressive deletion of the insert DNA. 
Metronidazole sensitivity assays were also carried out using the E. coli F19 parental 
strain E. coli CC1l8, in order to check that the sensitivity phenotype in E. coli F19 
was not due to a side effect of the transposon-mutagenesis of E. coli CC 118. The 
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MIC of E. coli CC1l8 plated on metronidazole was lower, as expected, due to an 
increase in the nitroreductase activity of the strain. E. coli CCI18 was still sensitive 
to metronidazole (MIC = 10 J.1g/ml) when transformed with pKS2, an exonuclease 
III-shortened clone that conferred the phenotype on E. coli FI9 , compared with a 
pKS control (MIC = 20 J.1g/ml). 
MIC 
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Fig. 2.1 Schematic diagram of a selection of the DNA constructs and the 
exonuclease TIl-shortened clones generated in this study. The corresponding MIe 
(minimum inhibitory concentration) of metronidazole for each construct in E. coli 
F19 is shown. Thick lines correspond to C. acetobutylicwn P262 DNA and thin 
lines correspond to vector DNA. 
A. Diagram of pMETlOB which contains 2.56kb of C. acetobutylicwn P262 insert 
DNA cloned into theBgill restriction site ofpEcoR251. 
B. Diagram of a 1.86kb HindIlI/PstI restriction fragment of C. acetobutylicwn 
P262 insert DNA from pMETIOB cloned into the HindIlI/PstI restriction sites of 
pKS and pSK, generating pKSIOB and pSKlOB, respectively. 
C. Diagram of a range of exonuclease ill-shortened clones generated from 
pKS lOB and pSKlOB. 
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2.3.3 Protein analysis 
In vitro cell-free transcription/translation experiments were carried out using a 
range of exonuclease ill-shortened clones to establish whether a protein was 
produced from the C. acetobutylicum P262 insert DNA of pKSl. First, the 
pSKIOB exonuclease ill-shortened clones were used in a transcription/translation 
experiment (Fig. 2.2). Lane 1 contained proteins expressed from pSK4 that did not 
confer the metronidazole sensitivity phenotype on E. coli F19. Lane 3 represented 
the pSK control and lanes 2, 4 and 5 represented proteins from pSK3, pSK2 and 
pSKl, respectively, all of which increased the sensitivity of E. coli F19 to 
metronidazole. No difference in the protein banding pattern could be detected 
between lane 1 and lanes 2, 4 and 5. This indicated that the production of a specific 
protein could not be correlated with the metronidazole sensitivity phenotype 
conferred by these constructs. 
1 2 3 4 5 
20.1" 
Fig. 2.2 In vitro transcription/translation experiment of the pSK constructs. 
Plasmid pSK4, that does not confer the metronidazole sensitivity phenotype on 
E. coli F19, was used for protein production in lane 1. Lanes 2, 4 and 5 correspond 
to constructs pSK3, pSK2 and pSKl, respectively, all of which confer the 
metronidazole sensitivity phenotype on E. coli F19. Proteins from the control 
plasmid pSK are shown in lane 3. Numbering indicates the positions and the sizes 
of molecular weight markers in kDa. 
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Four of the pKS lOB exonuclease III-shortened clones were used in a similar 
experiment (Fig. 2.3). Lane 1 contained proteins produced from the control 
plasmid pKS. Lane 2 contained proteins expressed from the pKS2 construct which 
made E. coli F19 sensitive to metronidazole. Lanes 3 to 5 contained proteins 
expressed from pKS3, pKS4 and pKS5, respectively, all of which had lost the 
ability to confer the metronidazole sensitivity phenotype. An overproduced protein 
band with an apparent molecular weight of approximately 15 kDa was visible in 
lanes 2 and 3. However, it appeared to be unrelated to the phenotype since it was 
produced from pKS2, which confelTed the phenotype and from pKS3 which had 
lost the ability to confer the phenotype on E. coli F19. To conclude, the pKS 
exonuclease III-shortened clones did not produce a protein band that correlated to 
the ability of the pKS constructs to confer the metronidazole sensitivity phenotype 
on E. coli F19. Although the prominent protein band in lane 2 of Fig. 2.3 was 
unrelated to the sensitivity phenotype, we speculated that it was the product of a 
fusion protein coded for partially by the pKS vector DNA and partially by the 
C. acetobutylicum P262 insert DNA. An A TG start codon located after the lac 
promoter in pKS (Stratagene Bluescript Instruction Manual) may have represented 
the site of translation initiation on the corresponding mRNA and a stop codon 
located in the C. acetobutylicum P262 insert DNA may have caused the 
termination of translation. Nucleotide sequencing (see Section 3.2.3) showed that a 
suitable stop codon was located at positions 670-672 in the insert DNA on the non­
coding strand of pKS 1. The vector would have contributed 92 nucleotides and the 
insert DNA 264 nucleotides to produce a fusion transcript of 356 nucleotides in 
length. A putative fusion protein would have been approximately 118 amino acids 
in length which corresponded to an apparent molecular weight of 13.4 kDa. This 
theoretical fusion protein may cOlTespond to the overproduced protein band seen in 
Fig. 2.3, since the smallest exonuclease III-sh0l1ened clone, pKS5, had the stop 
codon deleted and did not overproduce the protein. 
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1 2 3 4 5 

30" 
20.1 .. 
14.4 .. 
Fig. 2.3 In vitro transcription/translation experiment of the pKS constructs. 
Proteins from the control plasmid, pKS are shown in lane 1. Plasmid pKS2 that 
rendered E. coli F19 sensitive to metronidazole was used for protein production in 
lane 2. Proteins produced from constructs pKS3, pKS4 and pKS5 that did not 
confer the phenotype are shown in lanes 3, 4 and 5, respectively. Numbering 
indicates the positions and sizes of molecular weight markers in kDa. 
Thus, no protein band was observed from both in vitro transcription/translation 
experiments that corresponded to the ability of the metronidazole sensitivity 
phenotype to be conferred on E. coli F19 by the C. acetobutylicum P262 DNA. 
A second in vivo protein expression system was used that employed 17 RNA 
polymerase for the exclusive transcription of insert DNA (Tabor and Richardson, 
1985). This method was previously reported to reveal a protein product after initial 
in vitro transcription/translation experiments had failed to do so (Wehnert et al., 
1992). The unshortened subclone pKSI0B was transformed into E. coli AB1157 
with pGPI-2 that expresses the 17 RNA polymerase (see Section 2.2.4.2). The 
control bacterium was transformed with Bluescript pKS. Fig. 2.4 illustrates that no 
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differences in protein expression were detected for the plasmid pKS lOB (lane 2) 
that conferred the metronidazole sensitivity phenotype on E. coli F 19, compared to 
the control plasmid pKS (lane 1). 
1 2 

43 ~ 
30 ~ 
20.1 ~ 
14.4 .. 
Fig. 2.4 T7 promoter-directed expression of plasmid proteins in E. coli AB 1157. 
Lane 1 shows proteins produced from the control plasmid pKS . Lane 2 shows 
proteins produced from the subc10ne pKS 1OB that rendered E. coli F19 sensitive to 
metronidazole. Numbers show the positions of molecular weight markers in kDa. 
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2.3.4 Growth curve analysis 
A growth curve of E. coli JM10S transfonned with pKS2 that rendered E. coli F19 
susceptible to metronidazole, and E. coli JM10S transfonned with pKS4 that had 
lost the ability to make the bacterium susceptible, was detennined over an 11 h 
period (Fig. 2.S A). Both E. coli (pKS2) and E. coli (pKS4) followed a standard 
growth curve (Fig. 2.S A) and entered stationary phase at approximately the same 
optical density reading of A6O(}= 1.3. E. coli (pKS2) had a doubling time of SO min 
while E. coli (pSK4) had a doubling time of 44 min. The only observed difference 
was that E. coli (pKS2) hid a longer lag time of 1 h, but the growth characteristics 
of E. coli (pKS2) were that of a healthy culture and the construct did not cause any 
substantial alteration in tile growth curve under nonnal conditions. A graph of 
viable bacterial cell number versus time (Fig. 2.S B) showed that both cultures 
reached a viable cell count of greater than lOS cells per mI, but that E. coli (pKS2) 
took longer to reach this cell density. It can also be seen that the experimental 
culture contained 10-fold fewer viable cells than the control culture at the 11 h time 
point in the growth curve. The reduced viability of the E. coli cells was due to the 
presence of the additional insert DNA that pKS2 contained. This will be discussed 
further in Section 2.4. 
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Fig. 2.5 Standard growth curves of two E. coli IM105 cultures. Lines with open 
circles denote the E. coli control transfonned with pKS4 that had lost the ability to 
make E. coli F19 sensitive to metronidazole. Filled circles represent E. coli 
transfonned with pKS2 that rendered E. coli F19 sensitive to metronidazole. 
Results show the average of three experiments. 
A. Graph of the absorbance (OD 6OOnm) versus time (h). 
B. Graph of the log of the viable E. coli IM105 cell numbers versus time (h). 
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2.3.5 DNA hybridization 
The origin of the insert DNA of pMET10B was confmned by DNA hybridization 
(Fig. 2.6). 
A 1 2 3 4 5 6 8123456 
~1.86kb 
~O.77 kb 
Fig. 2.6 Gel electrophoresis and corresponding DNA hybridization to confmn the 
origin of the insert DNA of pKS lOB. 
A. Gel electrophoresis of E. coli chromosomal DNA (lane 2) and 
c. acetobutylicum P262 chromosomal DNA (lane 4) digested with HindIII/PstI 
endonuc1eases. Lane 6 contained C. acetobutylicum P262 chromosomal DNA 
digested with HindllI/EcoRI endonuc1eases. Lanes 3 and 5 contained pMETlOB 
DNA, digested to completion with HindlIl/PstI (lane 3) and HindIIIlEcoRI (lane 5) 
endonuc1eases. Lane 1 contained lambda DNA digested with PstI as a DNA size 
marker. Sizes of the lambda DNA markers in kb are detailed in the Appendix. 
B. Corresponding autoradiograph of the hybridization of a nonradioactively­
labelled 1.86kb HindIIIlPstI DNA probe from pKSlOB to A. Arrows and numbers 
in kb indicate the positions and sizes of the common bands between pMETlOB 
(lanes 3 and 5) and C. acetobutylicum P262 (lanes 4 and 6). 
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The nonradioactively-labelled DNA fragment hybridized to pMETIOB (lane 3) 
digested with HindIII/PstI endonucleases (Fig. 2.6). No specific hybridization 
between the probe and HindIII/PstI restriction endonuclease-digested E. coli JMI05 
chromosomal DNA occurred. A small amount of non-specific hybridization was 
observed in the top of lane 2. presumably due to the high concentration of E. coli 
chromosomal DNA. The probe hybridized to a corresponding 1.86kb 
C. acetobutylicum P262 HindIII/PstI-digested chromosomal DNA band in lane 4 
thus confrrming the origin of the pKSIOB insert DNA. An internal O.77kb 
HindIII/EcoRI restriction endonuclease band was common between the pMETIOB 
digest (lane 5) and the C. acetobutylicum P262 digest (lane 6). The top 4.5kb band 
of HindIII/EcoRI-digested pMETIOB DNA (lane 5) corresponded to a hybrid 
EcoRI/EcoRI band consisting of pEcoR251 vector DNA and C. acetobutylicum 
P262 insert DNA. 
2.4 Discussion 
Subcloning and exonuclease III shortening of the C. acetobutylicum P262 insert 
DNA of pMETIOB enabled the further characterization of the DNA by in vitro and 
in vivo transcription/translation experiments. metronidazole sensitivity testing and 
DNA hybridization. Metronidazole sensitivity tests showed that progressive 
exonuclease ill deletions of the insert DNA were associated with the complete loss 
of the phenotype for the pKS shortened constructs and with the partial loss of the 
phenotype for the pSK shortened constructs. 
SDS-polyacrylarnide gels of the in vitro transcription/translation experiment 
products did not reveal a specific protein band that was related to the metronidazole 
sensitivity phenotype that the relevant exonuclease III-shortened clones conferred 
on E. coli F19. In vivo transcription/translation experiments also failed to reveal 
Chapter Three 
Nucleotide sequencing and RNA studies 
3.1 Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 56 

3.2 Materials and methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 56 

3.2.1 Bacterial strains and plasmids. . . . . . . . . . . . . . . . . . . . . . . .. 56 

3.2.2 DNA preparation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 56 

3.2.3 Nucleotide sequencing. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57 

3.2.4 Sequence analysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57 

3.2.5 tRNA preparation and visualization. . . . . . . . . . . . . . . . . . . .. 58 

3.2.6 RNA hybridization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 58 

3.3 Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59 

3.3.1 Nucleotide sequencing and sequence analysis ofpKS1 . . . . . . . .. 59 

3.3.2 tRNA preparation and visualization. . . . . . . . . . . . . . . . . . . .. 64 

3.3.3 RNA hybridization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 64 

3.4 Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 66 

53 Chapter Two 
any protein that was associated with the ability to confer the metronidazole 
sensitivity phenotype on E. coli CCl18 and E. coli F19. 
The growth curves of E. coli JM105 (pKS2) and E. coli JMID5 (PKS4) were 
determined in LB without the addition of metronidazole to confirm that the 
metronidazole sensitivity was not due to a growth deficiency conferred on E. coli 
F19 by the C. acetobutylicum P262 insert DNA. Both E. coli JMID5, transformed 
with pKS2 that conferred the metronidazole sensitivity phenotype on the E. coli 
mutant F19, and E. coli JM105 transformed with a deleted plasmid pKS4, that did 
not confer the metronidazole sensitivity phenotype, followed a standard growth 
curve with E. coli (PKS2) showing an increased lag time of 1 hour. However, this 
lag time would not manifest itself in a metronidazole sensitivity plate assay after 2 
days growth at 34°C. The graph of bacterial cell numbers versus time showed that 
the nwnbers of viable cells in E. coli (PKS2) was reduced at 11 h compared to 
E. coli (PKS4). This was important since the metronidazole sensitivity phenotype 
observed was based on cell numbers. However, in the metronidazole sensitivity 
assays, the number of E. coli F 19 cells, transfOlmed with different constructs, was 
standardized to be the same on all plates containing no metronidazole. Thus, 
E. coli cell death at higher concentrations of metronidazole, was related to the 
transformed plasmid DNA and not to the plating of reduced cell numbers. Thus the 
observed metronidazole sensitivity phenotype was considered to be real and not 
artifactual. 
Finally, DNA hybridization established that the insert DNA of pKS 1 DB hybridized 
to pMET lOB and to the chromosomal DNA of C. acetobutylicum, but not to 
E. coli chromosomal DNA. The origin of the 1.86kb HindIIIIPstI insert DNA of 
pKS 1 DB was therefore confirmed to be from C. acetobutylicum P262. 
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It was considered that nucleotide sequencing of the C. acetobutylicum P262 insert 
DNA of pKSI would confinn the absence of an open reading frame, thus 
explaining the lack of an observable protein product linked to the metronidazole 
sensitivity phenotype. A protein may in fact have been produced from the pSKl 
C. acetobutylicum P262 insert DNA, but may have been masked by other proteins 
present in the SDS-polyacrylamide gels. However, if no protein was responsible 
for the metronidazole sensitivity phenotype, an RNA or other sequence motifs at 
the DNA level might have been responsible. Nucleotide sequencing of the pSK 1 
C. acetobutylicum P262 insert DNA was therefore undeltaken. 
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Nucleotide sequencing and RNA studies 

3.1 Introduction 
The C. acetobutylicum P262 insert DNA of pKS1, that originated from pMETI0B, 
was shown in Section 2.3.2 to transfonn E. coli F19 to a metronidazole sensitive 
phenotype. No protein product from the insert DNA, however, could be associated 
with this phenotype. This Chapter documents the nucleotide sequencing strategy 
used to characterize the DNA to try to identify the elements responsible for the 
sensitivity phenotype. RNA isolation and hybridization are reported in the second 
half of the Chapter (Section 3.3.2 and 3.3.3). 
3.2 Materials and methods 

All details of materials and methods are contained in the Appendix. 

3.2.1 Bacterial strains and plasmids 

Bacterial strains used were the same as those reported in Fig. 2.1 in Section 2.1.1. 

3.2.2 DNA preparation 

DNA for nucleotide sequencing and general use was prepared according to Ish­

Horowicz and Burke (1981). The maxiprep method was used (see Appendix) 

followed by cesium chloride gradient centrifugation in order to generate a pure 
preparation which was necessary for good resolution on sequencing gels. 
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3.2.3 Nucleotide sequencing 
The nucleotide sequence of both strands of the C. acetobutylicum P262 insert DNA 
of exonuclease III-shortened clone pKSl was detennined by an adaptation of the 
dideoxynucleotide triphosphate chain tennination method of Sanger et ai. (1977). 
The Sequenase® Version 2.0 DNA Sequencing Kit was used (No. 70700, United 
States Biochemical, Cleveland, Ohio, USA) which incorporates the Sequenase® 
enzyme originally described by Tabor and Richardson (1987). Two oligonucleotide 
primers that were designed to be complementary to an internal region of the insert 
DNA were used for nucleotide sequencing and were synthesized by Prof D. Botes 
in the Biochemistry Department, ucr. The M13 forward and reverse sequencing 
primers from the kit were also used. Extensive compressions were located in some 
areas of the DNA template and in order to resolve them, Klenow polymerase was 
added to the sequencing tennination reactions (see Appendix). 
3.2.4 Sequence analysis 
The sequencing data was analyzed using the sequence analysis programs of the 
Wisconsin University Genetics Computer Group Inc. (Devereux et ai., 1984) on a 
VAX-6000-330 computer. The GenBank, EMBL, SWISS-Protein and PIR 
databases were searched directly for DNA and amino acid homology. Databases 
were also accessed using the BLAST network service (Basic local alignment search 
tool) through the NCBI (National Centre for Biotechnology Information), 
Maryland, USA, (Altschul et ai., 1990). The centre was accessed via electronic 
mail to the NCBI BLAST E-Mail Server (blast@ncbi.nlm.nih.gov). The BLOCKS 
E-Mail searcher (blockS@howard.fhcrc.org) was also used to detect any sequence 
homologies between the query sequence and the current database of protein blocks 
at the NCBI. The BLOCKS E-Mail searcher is based on the PATMAT searching 
tool and can search protein or DNA sequences (Wallace and Henikoff, 1992). The 
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tRNA Search program was also used to analyze the sequence information (Dr. P. 
DUrre, Institute for Microbiology, Gottingen, Germany, pers. comm.). 
3.2.5 tRNA preparation and visualization 
C. acetobutylicum P262 was grown under anaerobic conditions in Clostridium basal 
medium (O'Brien and Morris, 1972). E. coli JM105 was grown in LB containing 
100 Ilg/ml ampicillin. RNA was isolated from both C. acetobutylicum P262 and 
E. coli JM105 using hot phenol, according to the method of Aiba et al. (1981). 
RNA was separated on a 2.5% denaturing agarose gel (Fourney et al., 1988) and 
was subsequently vacuum-blotted onto Hybond N+ (Amersham Int., Amersham, 
UK) for 45 min using 0.05M NaOH. RNA markers were obtained from Gibco Brl, 
Maryland, USA. 
3.2.6 RNA hybridization 
The 1.86kb HindIIl/Pstl C. acetobutylicum P262 DNA restriction endonuclease 
fragment from pMET10B was used as a probe for RNA hybridization. The gel­
purified DNA fragment was further purified using the Geneclean Kit (BIO 101, La 
Jolla, California, USA). The DNA fragment was random-primed with [a._32P]CTP 
(3000 Ci/mmol) using the Random Primed DNA Labelling Kit (No. 1004 760, 
Boehringer Mannheim (SA)). Hybridization and detection were according to the 
instructions of Amersham Int., Amersham, UK. Methods for both tRNA 
preparation and RNA hybridization are contained in the Appendix. 
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3.3 Results 
3.3.1 Nucleotide sequencing and sequence analysis ofpKSI 
The pKS and pSK exonuclease III-shortened clones and two oligonucleotide 
primers were used for nucleotide sequencing of the 933-bp C. acetobutylicum P262 
insert DNA of pKSl. Homology searches of l00-bp sections of nucleotide 
sequence at the DNA level revealed two genes coding for two transfer RNA-like 
structures. The putative tRNAs contained the unmodified anticodons UGA and 
GCU that corresponded to the serine codons UCA and AGC respectively (Fig. 3.1). 
The tRNA Search program also confmned that the DNA encoded two tRNA genes 
(Dr. P. Dtirre, Institute for Microbiology, Gottingen, Germany, pers. comm.). Both 
tRNA genes were 91-bp in length and were separated by a 34-bp spacer. They were 
transcribed from the same strand and both encoded the 3' CCA terminus of the 
acceptor arm. Both tRNAs were typical of class II tRNAs as they conformed to the 
predicted cloverleaf structure (Fig. 3.2) and each included a large variable extra arm 
of 15-bp and 14-bp for tRNASer AGC and tRNASer UCA, respectively. Analysis of 
upsteam sequence revealed a region with very strong homology to both consensus 
E. coli and consensus Gram-positive bacterial -35 and -10 Pribnow box promoter 
regions (Fig 3.1). In addition, a 7-bp region showed homolgy to a consensus SC 
(stringent control) sequence GT(C{f)G(C{f)(T/Pu) from B. subtilis (Ogasawara et 
al., 1983). Analysis of the downstream sequence revealed a 13-bp inverted repeat 
sequence, located immediatedly after the second tRNA gene, that could form a 
putative rho-independent transcription termination stem structure (~G = ­
27kCal/mol), (Rosenburg and Court, 1979). A third 13-bp sequence, 22-bp 
downstream of the putative terminator showed extensive homology to the putative 
terminator structure and could possibly form a stem structure (with 4 mismatches) 
with one of the strands of the terminator (~G = -20kCal/mol). 
--
1 
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ACGAAAATTA TGATAAAATC AAAAATATTA CGATAATGTT TGAAAGTATC 
51 AAAAAATATA TTGTGCTAAG CAAAGTTTAG TGTTATATAT ATGGTACAAT 
Putative LexA site EcoRIJ.. 
101 ATGATTTATT CATTACTTAG TGATACTGTA CATAACTTTA ATTTAGAATT 
151 CAATTTTTAA CATATATATT TCTTTATTTT ATTATATGGA AAGTTATAAA 
ApoIJ.. 
201 AATAAAATTT TAAACTATTC ATTTCATAAT TTAGATTTTT CAATAAAATT 
251 AAGTTAATGT TGCTCATTTT AATATAAATT GTCCTTGGTA AAATATACAT 

·35 ·10 

301 TAATGAAAAA TAAAAAAATA TGTTGACACA TATTAAAATC ATTGCTATAA 

SC region 

351 TAAATCATGT CGTGAGACGT GGAAAGATGG TCGAGTTGGT TTAAGGCACC 

tRNASeruCA 

401 GGTCTTGAAA ACCGGCGTGC GTGTAAGCGT ACCTAGGGTT CGAATCCCTA 
451 TCTTTCCGCC ATTTAATATA ATAATAAAAA ATGCAGAAGG CACATGGAGA 

tRNASerAGC 

501 ATTACTCAAG TGGCTGAAGA GGCGCCCCTG CTAAGGGCGT AGG'l'CGGGTA 
551 ACTGGCGCCC GGGTTCAAAT CCCGGATTCT CCGCCAAAAA CATCTAACAT 
> 
601 TATGTTAGAT GTTTTTTTGT TTTGTAAATT TTTATATAAT CATTTATTAT 

< ---> 

651 ATATTTTAAT ACTTATTTCT AAAAAGTTAC AGTATTGAAT AATATATTAT 

701 AAAGCAAAAA TATAATGATG ATACATAGTA TAATTATATA AGAGAGATTA 
751 ATCAGATAAG AAGGTGCATT GTGCTTAAAG GAGAGAAAAT ATATTTAAGG 
801 TTACTTGAGA AAAGGGATAT ATTAATGTTG CATAAGTTAT GTAATGAAGA 
851 GGAAGTTAAA AAATACAATA TAATATCGAG TGATATTAAT GAATATAAAA 
HindlIIJ.. 
901 ATAATCTCAA ACAGACAAAC TTAAGAAAAG CTT 
Fig. 3.1 DNA nucleotide sequence of the non-coding strand of the 933-bp 
C. acetobutylicum P262 insert DNA of pKSl encoding the two serine tRNA genes. 
The tRNA genes are shown in bold with the anticodons in italics. The -35 and-1O 
promoter regions and the stringent control (SC) sequence are underlined. The 13­
bp inverted repeat sequences that may form a terminator structure are underlined 
by arrows, with the mismatched repeat sequence indicated by a multiply dashed 
arrow. The position of a putative LexA binding sequence is indicated by a double 
underline. The nucleotide sequence depicted here has been submitted to the 
GenBank: sequence database and has been accorded accession number L24102. 
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Fig. 3.2 The predicted secondary structure of two serine tRNA molecules from 
C. acetobutylicum P262. The primary sequence of the tRNA molecules was 
obtained from the insert DNA sequence of pKSI in Fig. 3.1. The structures 
predicted are according to the tRNA Search program (Dr P. Diirre, pers. comm.). 
Numbering is according to standard methods (Sprinzl et al., 1989). 
It was initially assumed that the two tRNA genes were related to the metronidazole 
susceptibility phenotype conferred by pKSI on E. coli F19. However, the position 
of the tRNA genes on the various exonuclease III-shortened clones did not appear 
to be related to the ability of the constructs to make E. coli F19 susceptible to 
metronidazole (Fig. 3.3). In an attempt to confmn this, further subcloning of pKSI 
was carried out and further E. coli F19 metronidazole susceptibility assays were 
conducted. Subclone B (Fig. 3.3) was generated by the ligation of a O.79kb 
EcoRIIHindIII restriction endonuclease C. acetobutylicum P262 insert DNA 
fragment from pKSI0B, containing the two tRNA genes, into the EcoRl/HindIII 
restriction sites of pKS. Subclone A (Fig. 3.3) was generated by the ligation of a 
0.43kb ApoI endonuclease-digested DNA fragment of the C. acetobutylicum P262 
insert DNA into the compatible EcoRI restriction site of Bluescript pKS. Both 
subclones did not make E. coli F19 more susceptible to metronidazole than a 
- -
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control plasmid pKS, indicating conclusively that the tRNA genes were not 
responsible for the phenotype. 
MICPutative 
of 
LexA metronidazole 
binding site ug/mltRNA(UCA) tRNA(AGC) 
pKS1 15
•pKS2 15
•pKS3 c::= 35 
pKS4 35 
pKS5 35 
pSK4 20 
pSK3 15
•pSK2 15
•pSK1 15
• 
A 35 

B 35 

o 500 1000 bp 
Fig. 3.3 Schematic diagram of a range of C. acetobutylicum P262 DNA inserts 
generated in Bluescript pKS and pSK and the relative positions of the two tRNA 
genes. The extent of the C. acetobutylicum P262 inserts of the subclones A and B 
are shown. Thick lines indicate C. acetobutylicum P262 DNA for which the 
nucleotide sequence was determined, while thin lines indicate the unsequenced 
DNA region. Vector DNA is not indicated. The tRNA genes are depicted as blank 
boxes and the oligonucleotide primers used for nucleotide sequencing are shown as 
arrows. The presence of the putative LexA binding sequence is indicated by a 
filled circle and its relationship to the phenotype (minimum inhibitory 
concentration of metronidazole) in E. coli Fl9 is shown. 
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Coincidentally, it was noted that a sequence was present that had homology to an 
E. coli LexA binding site. This sequence was present upstream of the tRNA genes 
on all the constructs that conferred the metronidazole sensitivity phenotype, but was 
absent from those that did not (Fig. 3.3). LexA is a repressor protein that regulates 
many of the E. coli SOS genes that are involved in bacterial DNA repair. Whether 
LexA in fact binds to this C. acetobutylicum P262 sequence in E. coli F19 is 
unknown since the sequence has 6 mismatches out of a 16-bp consensus sequence 
as shown in Fig. 3.4 (Wertman and Mount, 1985). However, the nucleotide 
sequences of the different E. coli LexA binding sites vary considerably, indicating 
that a range of nucleotides can be accommodated by the protein. 
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Fig. 3.4 Nucleotide sequence alignment of a consensus LexA binding site from 
E. coli (A), with a putative LexA binding sequence on the C. acetobutylicum. P262 
insert DNA ofpKSI (B). Horizontal dashes indicate nucleotides that exhibit dyad 
symmetry in the consensus site while asterisks indicate identical nucleotides 
between the consensus site and the C. acetobutylicum. P262 sequence. Numbering 
represents the position of nucleotides within the consensus operator half-site (for 
details see text), (Wertman and Mount, 1985). 
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3.3.2 tRNA preparation and visualization 
Plasmid-encoded tRNA was isolated together with endogenous bacterial tRNA as 
part of a bulk RNA preparation from C. acetobutylicum P262 and E. coli JMI05. 
The endogenous and plasmid-encoded tRNA species could be visualized by 
electrophoresis on a denaturing 2.5% agarose gel (Fig. 3.5 A.) which separated the 
tRNA from the bulk RNA. Lane 1 contains RNA isolated from E. coli JMI05 
transformed with pKS2, encoding the two tRNA genes. Lane 2 contains RNA 
isolated from E. coli cells transformed with the plasmid pKS5 in which both tRNA 
genes had been deleted, as a negative control. Total RNA isolated from 
C. acetobutylicum P262 is shown in lane 3. The transfer RNA was observed as a 
band immediately below the 5S rRNA band. The 23S rRNA and 16S rRNA bands 
were visible higher up in the gel. RNA markers were visible as six faint bands 
(lane 4) which corresponded in increasing size to O.24kb, 1.4kb. 2.4kb. 4.4kb and a 
top band which appeared as a doublet of 7.5kb and 9.5kb. 
3.3.3 RNA Hybridization 
Northern hybridization was carried out to confmn whether it was possible to 
distinguish between the plasmid-encoded serine tRNAs and the endogenous E. coli 
JMI05 tRNAs. Northern hybridization also confmned that the two serine tRNA 
molecules were produced in C. acetobutylicum P262. The 0.43kb 
C. acetobutylicum P262 ApoI-digested DNA fragment that encoded the two tRNA 
genes. was used as a probe. Hybridization was observed in lane 1 (Fig. 3.5 B) to 
tRNA produced from E. coli containing the plasmid pKS2 encoding the tRNA 
genes. No hybridization was observed in lane 2 to tRNA produced from E. coli 
containing the deletion plasmid pKS5. This indicated that the hybridization 
observed was to plasmid-encoded tRNA since no signal was observed in lane 2. 
Stronger hybridization was observed to tRNA produced from C. acetobutylicum 
P262 in lane 3, than to tRNA produced from E. coli in lane 1. A very faint band 
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was observed in both lanes 1 and 3, just above O.24kb and may correspond to the 
position of the primary transcript which would be approximately 220 nucleotides in 
length. 
A 1 2 3 4 B 1 2 3 

tRNA .... 
Fig. 3.5 Northern analysis of tRNA produced from E. coli JM105 and 
C. acetobutylicum P262. 
A. Denaturing gel electrophoresis of total RNA produced from E. coli transformed 
with pKS2 encoding the two tRNA genes (lane 1) , transformed with pKS5 which 
had the two tRNA genes deleted (lane 2). Lane 3 shows total RNA produced from 
C. acetobutylicum. Lane 4 shows RNA markers (see text for sizes). 
B. Northern hybridization of RNA in A to the [a_32P]-labelled ApoI 
C. acetobutylicum P262 DNA restriction fragment containing the two tRNA genes 
(depicted as A in Fig. 3.3) as a probe. 
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3.4 Discussion 
The two serine tRNA genes from C. acetobutylicum P262 showed high homology 
to the corresponding serine tRNA genes from other bacterial species, presumably 
due to the large number of nucleotides that are conserved in these molecules 
(Lewin, 1987). tRNASerAGC showed 70.2% identity to the E. coli tRNASerAGC 
and 89% identity to the B. subtilis tRNASerAGC (Sprinzl et aI., 1989; Green and 
Void, 1983). Likewise, the tRNASerUCA showed 76.9% identity to the 
synonymous tRNA from E. coli and 69.9% identity to the synonymous B. subtilis 
tRNA. In addition, tRNASer UCA shared 67.4% identity with the corresponding 
tRNA in Streptomyces griseus, illustrating the sequence similarity between species 
(Bar-nir, 1992). 
The organization of the genes suggested that they were transcribed as one 
transcriptional unit; they were preceded by a consensus promoter sequence and 
followed by three repeated sequences that may have formed a putative transcription 
terminator. The putative promoter region showed strong consensus to both typical 
E. coli promoters and Gram-positive vegetative promoter regions. 
Graves and Rabinowitz (1986) reported that a cluster of A residues, conserved at 
positions -45 to -41 in more than 50% of the Gram-positive promoters analyzed, 
was thought to represent an extended promoter consensus sequence. An identical 
sequence (TA_AAAAA) was present upstream of the promoter sequence identified 
in this study. Fig. 3.6 shows the alignment of this promoter with other consensus 
E. coli, Clostridium and Gram-positive promoter regions. No unique recognition 
sequences upstream of Clostridium operons have as yet been identified to be 
recognized by alternate sigma factors. It is likely, though, that this tRNASer operon 
is routinely transcribed by C. acetobutylicum P262 and the consensus-like nature of 
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the putative promoter may reflect the continued requirement of these molecules by 
the bacterium. 
-35 REGION -10 REGION 
E. coli consensus ---A------T-TTGACAT--T------- -T-TG-TATAAT----­
Gram-positive consensus TA-AAAAA---GTTGACA---A--A---A -T-TG-TATAATAATAT 
Clostridium consensus -----T------TTGACA-----T-----AATATGATATAAT---T­
** ***** ******** * * ** ******** ** 
C. acetobutylicum P262 TAAAAAAATATGTTGACA-CATATTAAAATCATTGCTATAATAAAT 
putative tRNASer operon promoter 
Fig. 3.6 Alignment of the putative C.acetobutylicum P262 tRNASer operon 
promoter with consensus promoter sequences from E. coli, Clostridium and Gram­
positive bacteria. Asterisks indicate identical nuc1eotides. Adapted from Gerischer 
and Diirre (1992). 
An additional control element, the SC (stringent control) or discriminator sequence, 
has been identified upstream of a number of RNA genes in Gram-positive and 
Gram-negative bacteria. SC sequences are thought to negatively regulate a number 
of components of the translation machinery, such as some rRNAs and tRNAs, 
under conditions of amino acid starvation (Cashel and Rudd, 1987). A consensus 
SC region was frrst identified in E. coli to be CggC-CC. where it lies immediately 3' 
to the Pribnow box of promoters negatively regulated during the stringent response 
(Travers, 1980). In Gram-positive B. subtilis. however, the consensus sequence is 
different; GT(C{f)G(C{f)(T/Pu) and its position corresponds to the putative 
transcription initiation site (Ogasawara et ai., 1983). The 7-bp region reported in 
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this study showed homology to the B. subtilis SC sequence and was situated 7-bp 
after the -10 Pribnow box region, similar to the SC sequence position in that 
bacterium. The presence of the SC sequence may indicate that this putative 
C. acetobutylicum P262 serine tRNA operon is subject to stringent control. An SC 
sequence that was identified in P. aeruginosa was of the E. coli-type (Bally et al., 
1992) indicating that the currently reported examples of control elements indicate 
differences between Gram-positive and Gram-negative organisms. The only other 
report of a tRNA gene from C. acetobutylicum P262 showed no obvious promoter 
or SC region (Sauer and Dtirre, 1992). This is therefore, the first example of a 
C. acetobutylicum P262 tRNA gene cluster with a consensus promoter and stringent 
control region, indicating that the stringent response probably operates in this 
bacterium. 
The termination of transcription in E. coli may be factor dependent (eg. rho­
dependent) with these terminators exhibiting no obvious sequence similarities 
(Roberts, 1969). A factor-independent terminator was identified in this study and 
consisted of a typical GC-rich region that exhibited dyad symmetry followed by a 
string of Ts. A third repeat sequence was also identified, which could base-pair 
with the second repeat sequence located after the tRNA genes. A similar situation 
was observed in E. coli, where a third I1-bp sequence could base-pair with one of 
the strands of the putative terminator located after the tRNASer UCA gene (Tamura 
et al., 1984). 
The two tRNA genes have an unusually high percentage of G + C for Clostridium 
spp. C. acetobutylicum is characterized by a low G + C content of 28% to 29% 
(Cummins and Johnson, 1971). The tRNASer AGC gene is 60% G + C, while the 
tRNASer UCA gene is 53% G + C. This high G + C content is presumably required 
for the stability of the tRNA molecule. However, the G + C composition for the 
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entire 933-bp sequenced region is 27%. The codon recognized by the rust tRNA in 
the operon, AGC, is used only moderately by C. acetobutylicum P262 (12% of the 
time). The second tRNA recognizes the codon UCA, which is used the most 
frequently out of all the synonymous serine codons (41% of the time), (J. 
Santangelo, PhD Thesis, UeT, 1991). 
Since the tRNAs in this study were sequenced at the DNA level, but not at the RNA 
level, the predicted codon-anticodon recognition is based on the unmodified 
anticodon sequence. The influence of modification on the codon-anticodon 
interaction is not well understood but it is known to affect the nature of the 
recognition. Indeed, Wahab et al. (1993) showed that a 7-fold increase in tRNALeu 
levels in E. coli caused at least 90% of the tRNA to be hypomodified. This 
hypomodification may have altered the codon-anticodon recognition which may 
explain the reduced growth rates they observed. 
It is likely that the uridine in the rust position of the anticodon of C. acetobutylicum 
P262 tRNASer UCA is post-transcriptionally modified since nearly all uridines are 
modified at this position, except for a few cases (Sprinzl et al., 1989). NMR studies 
have examined the effect of a modified uridine at this position on the mechanism of 
codon recognition (Yokoyama et al., 1985). It appears that two types of modified 
uridine prevail; xm5s2U or x05U (Fig. 3.7). In B. subtilis, 5-methoxyuridine (m05U) 
has been detected in tRNAVaI, tRNAThr and tRNAAla, whereas in E. coli, 
modification has been of the cmoSU and mnm5s2U type. The modified uridine 
xm5s2U, maintains the ribose ring in its usual form and can form a stable base pair 
with adenine only. However, x05U has a flexible ribose ring and can base pair with 
uridine and guanine as well as adenine. If we assume that the modification in 
C. acetobutylicum P262 is of the same type as that in B. subtilis (moSU), then the 
UGA anticodon oftRNASer UCA can also recognise codons UCU (used 21 % of the 
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time in C. acetobutylicum P262, (1. Santangelo, PhD Thesis, vcr, 1991)) and VCG 
(used 2.4% of the time), 
0 	 5 xo U 
H, /c"s/o-x" 
N 	 C ho 5U [X = HI 
I 	 II 
C 	 C 
0-7 'N/ "H mo 
5U [X = CH31 
-I 	 cmo 5U [X =CH COO 1Ribose 	 2
0 
II 	 5xm s 2UH'N/C,,~/CH2-x 
I 	 II m5s 2U [x = HJ C C 
<f/2'N/ "H 5 + 
S 	 I mnm s 2U [x NH 2CH3 1 
Ribose 
Fig. 3.7 Chemical structure of modified uridines (Yokoyama et ai., 1985) 
Similarly a wobble, as proposed by Crick (1966), in the guanine of the fIrst position 
of the anticodon of tRNASerAGC means that this tRNA can also recognise codon 
AGV as well as AGC. AGV is used 22% of the time out of the group of 
synonymous serine codons in C. acetobutylicum P262 (1. Santangelo, PhD Thesis, 
VCT, 1991). In theory therefore, up to 5 synonymous serine codons, out of a total 
of 6 could be recognised by the two serine tRNAs present on the C. acetobutylicum 
P262 insert DNA of pSKI. One can speculate that C. acetobutylicum P262 may 
limit the number of tRN A genes by preferring anticodons capable of reading more 
than one codon. However, it is possible that duplicate copies of these tRNA genes 
are present on the C. acetobutylicum P262 chromosome, as in the case of some 
B. subtilis tRN A genes (VoId, 1985). 
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The position of the two tRNA genes on the exonuclease III-shortened clones 
indicated that they were not related to the ability of certain constructs to render 
E. coli F19 sensitive to metronidazole. Two other subclones, A and B, were 
generated in an attempt to prove this. The biggest subclone, subclone B, contained 
787-bp of C. acetobutylicum P262 DNA which included the two tRNA genes of the 
933-bp sequenced region of the insert DNA of pKS L Yet, it did not render E. coli 
F19 sensitive to metronidazole. Therefore the 146-bp region, upstream of the 
EcoRI site in pKS1, was examined again. As before, no open reading frame could 
be detected and homology searches using BLAST and BLOCKS revealed no 
relevant homology to known protein or DNA sequences in the existing databases. 
However, on searching the DNA sequence visually, a 16-bp sequence that showed 
homology to an E. coli LexA binding site was noted, 230-bp upstream of the tRNA 
genes. 
LexA is a small repressor protein (22 300 Da) that represses a number of unlinked 
genes of the SOS regulon, that are involved in the repair of DNA damage in the cell. 
The nucleotide sequences of a number of LexA repressor sites are known and on the 
basis of 25 sites, a 16-bp consensus sequence was proposed (Wertman and Mount, 
1985). This sequence has a central axis of symmetry which divides the site into an 
operator half site. This is based on the idea that a dimer repressor binds 
symmetrically to the operator site about this axis, making identical contacts with the 
nucleotides present in the site if the second monomer is swung through 1800 relative 
to the binding position of the first (Fig. 3.4). The terminal trinucleotide CTG is the 
most conserved, but homology among the central five nucleotides is also conserved 
between sites. The sequence observed in this study on pKS 1, has an almost perfect 
consensus sequence for the first 8 nucleotides. The second half-site, however, has 
only 3 out of 8 consensus nucleotides. There are six deviations from the consensus 
in the C. acetobutylicum P262 sequence which may be sufficient for binding since 
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one of the umuDC operators has eight deviations and still binds the repressor 
(Wertman and Mount, 1985). The presence of this C. acetobutylicum P262 
sequence, with homology to E. coli LexA binding sites, could perhaps be 
responsible for the metronidazole sensitivity phenotype observed in E. coli F19. 
This will be discussed in the General Discussion and Conclusion in Chapter Four. 
Lastly, the RNA hybridization experiment proved that the relevant tRNA molecules 
were transcribed from C. acetobutylicum P262 DNA, both in the parent organism 
and in the heterologous host, E. coli JMI05. Thus the Gram-negative E. coli RNA 
polymerase recognized and transcribed the Gram-positive C. acetobutylicum 
promoter. This is not unexpected since a number of Gram-positive genes have been 
expressed successfully in E. coli and the problem lies rather in the expression of 
E. coli genes in Gram-positive bacteria (Graves and Rabinowitz, 1986). Northern 
blotting showed that no hybridization of a DNA probe encoding the two tRNA 
genes, occurred to tRJ'JA produced from the control E. coli, which contained a 
plasmid that had been deleted for both tRNA genes. This was unexpected since the 
two endogenous E. coli tRNASer molecules showed more than 700/0 identity to their 
C. acetobutylicum P262 counterpal1s. A lowering of the stringency conditions may 
result in cross-hybridization. The tRNA from C. acetobutylicum P262 also 
produced a stronger hybridization signal than the tRJ'\1A from E. coli. This may 
have been due to unequal amounts of tRNA loaded in the agarose gel, however, it is 
not possible to detect this visually on the gel photograph. An alternative 
explanation is that the proportion of the two serine tRNA species relative to the total 
amount of tRNA produced, may have been larger in C. acetobutylicum P262. This 
may have been due to the increased recognition of the C. acetobutylicum P262 
endogenous promoter in the parent organism relative to its recognition in E. coli. 
Chapter Four 
General discussion and conclusion 
The work presented in this thesis has provided further infonnation about the 
genetics of C. acetobutylicum P262. An improved understanding of the genetics of 
this bacterium is vital for the future genetic manipulation of pathways involved in 
solvent metabolism. This work has given insight into C. acetobutylicum P262 
serine tRNA genes and has raised interesting questions regarding a putative LexA 
sequence that was found upstream of the two tRNA genes on pKS 1. The putative 
LexA sequence will be discussed with reference to how it may have generated the 
metronidazole sensitivity phenotype in E. coli F19. Other genes that have been 
isolated and characterized in this laboratory using the metronidazole system and the 
E. coli F19 mutant will also be mentioned. From this infonnation. suggestions will 
be made concerning future research in C. acetobutylicum P262. 
LexA is a repressor protein that during nonnal cell growth in E. coli. represses a set 
of about 20 SOS genes. The SOS regulatory system represents about 0.5% of all 
E. coli genes and controls the response of the cell to DNA damage or DNA 
replication inhibition (Little. 1993). The SOS system includes the uvrABCD genes 
for excision repair and the recBCDEF genes for recombinational repair, some of 
which are under control of the LexA and RecA proteins. In a nonnal cell, LexA 
differentially represses a number of these repair genes, including its own structural 
gene by binding to a range of operator/promoter sequences. It binds tightly to the 
recA gene, while binding less tightly to its own operator and the uvrA operator so 
that a basal level of certain repair proteins is maintained in the cell (Walker, 1984). 
It is known that the addition of metronidazole to an E. coli culture causes DNA 
damage to the bacterium (Jackson, 1984) that would induce the SOS response in a 
similar way to UV (ultraviolet) light or other mutagens. The DNA damage is 
74 Chapter Four 
thought to induce a signal that results in the reversible activation of the RecA 
protein to a coprotease that increases the rate of cleavage of the LexA repressor 
CVValker, 1987). Upon cleavage the repressor is inactivated and the SOS genes are 
expressed. LexA can in fact cleave itself at high pH and RecA stimulates the self­
cleavage process, by acting as a coprotease (Little, 1993). It is likely that self­
cleavage of LexA occurs continuously at a slow rate and that the interaction with 
activated RecA increases the rate of cleavage dramatically. Cleavage of the 
repressor then results in the increased expression of the SOS genes and the 
damaged DNA is repaired thus removing the inducing signal. RecA is, therefore, 
no longer induced to act as a coprotease and it reverts to its original inactivated 
state. LexA protein is continuously synthesized throughout the above process and 
binds to a range of operators/promoters of the SOS genes once again before finally 
repressing its own structural gene. 
The E. coli strains F19 and CC1l8 used in this study were recA so the above 
situation is altered, but to what extent is unknown. The MIC of metronidazole for 
strains E. coli F19 and E. coli CC1l8 that are mutated in their DNA repair genes is 
much lower that that for parent strains (Jackson, 1984) but the bacteria still manage 
to survive exposure to DNA damage. When pKSI was present in an E. coli Fl9 
cell, however, the sensitivity to metronidazole was further increased, as discussed in 
Section 2.3.2 and 3.3.1. We can only speculate at this stage as to the mechanism of 
this increased sensitivity, because many details of the repair process are unknown. 
One possibility is that the 16-bp sequence upstream of the two tRNA genes 
mimicked an E. coli LexA binding site that binds any available LexA repressor 
protein. One might expect that the sequestration of the LexA repressor would lead 
to a derepression of the repair genes under LexA control and a resistance 
phenotype. This is incompatible with the findings of this study which showed that 
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the E. coli F19 mutant was sensitive to the drug when transformed with pKSl. 
However, the sensitivity phenotype may have been caused by the continuous 
overproduction of the LexA protein by the cell. If available LexA protein was 
sequestered from some of the SOS gene operators by the 16-bp C. acetobutylicum 
P262 sequence, it is likely that the lexA structural gene continued production of the 
protein because a certain concentration of LexA repressor was probably required in 
the cell before autorepression of the lexA structural gene occurred. Thus, the 
presence of multicopy plasmids bearing a number of artifactual LexA binding sites 
would have required the cell to produce abnormally increased amounts of the 
repressor protein. The increased expression of such a protein may have 
disadvantaged the cell by titrating cell machinery normally required for the 
transcription and translation of other essential genes. Such a load on the cell may 
have caused the metronidazole sensitivity phenotype observed in this study. 
In order to test this hypothesis, the binding of LexA to such a sequence would frrst 
need to be demonstrated in a gel retardation experiment. A synthetic 
oligonucleotide should preferably be used which includes the 16-bp putative LexA 
sequence. This would eliminate the possibility of other nonspecific binding events. 
The oligonucleotide should be labelled at the 5' end using [o._32P]CTP and T4 
polynucleotide kinase and then incubated for 30 min with varying concentrations of 
LexA protein (from 5nM to 200nM). Binding could then be detected as retardation 
of the oligonucleotide after polyacrylamide gel electrophoresis and 
autoradiography. 
A number of other C. acetobutylicum P262 genes have been isolated and 
characterized in this laboratory using the E. coli F19 mutant and the metronidazole 
system. These include a catabolite repressor of alpha-amylase (S. Davison, pers. 
comm.), a putative glutamate synthase small subunit - gltD (H. Stutz, pers. comm.) 
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and a spoIID gene (K. Hancock, pers, comm.) as well as the flavodoxin and 
hydrogenase genes fIrst isolated using the system (Santangelo et ai., 1991). In 
tenns of an explanation for the genes isolated, the electron transport genes 
(flavodoxin and hydrogenase) agree with the theory: an E. coli F19 cell 
transfonned with a recombinant plasmid encoding electron transport genes, will 
contain increased amounts of the reduced, toxic intennediates of metronidazole and 
will be rendered more sensitive to the drug than E. coli F19 containing a control 
plasmid. However, other genes not involved in electron transport in 
C. acetobutylicum P262 have been isolated using this system. The putative gitD 
subunit of glutamate synthase, although not part of the electron transfer system, 
may donate electrons to the large subunit of the enzyme which may account for its 
reductive properties in E. coli F19. However, the reasons as to why a catabolite 
repressor and a spoIID gene from C. acetobutylicum P262 should be isolated on the 
basis of a metronidazole sensitivity phenotype, are unknown at this stage. Thus, 
although some success has been achieved in the cloning of electron transport genes 
from C. acetobutylicum P262 with the metronidazole system, it has been limited. In 
the future, the establishment of alternative methods for the cloning of such genes 
may prove to be more profitable. 
In the study presented in this thesis, two serine tRNA genes were located adjacent 
to a region responsible for a metronidazole sensitivity phenotype in E. coli F19. 
Their isolation was fortunate as they represent only the second example of tRNA 
genes that have been isolated from C. acetobutylicum P262. A sequence that had 
homology to a consensus stringent control sequence from B. subtilis was identified 
upstream of the putative tRNASer operon, which provides the fIrst indication that the 
stringent response may operate in C. acetobutylicum P262. The organisation of the 
genes and transcriptional control elements, such as a putative promoter and 
terminator, suggests that the genes may be transcribed as one unit. Northern 
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hybridization experiments showed a faint band of approximately 240 nucleotides 
that may have corresponded to the position of a putative primary transcript. 
However, primer extension experiments and Sl-nuclease mapping data would be 
needed to confmn this. The work presented in this thesis represents the fIrst 
information available about the organisation of clustered tRNA genes on the 
C. acetobutylicum P262 chromosome. Further analysis and sequencing of tRNA 
genes would be needed to confmn whether clustering of tRNA genes is common on 
the C. acetobutylicum P262 chromosome. Such clustering would enable the 
coordinate transcription and processing of C. acetobutylicum P262 tRNAs which 
may facilitate the rapid activation of the translation machinery during spore 
germination and outgrowth in this bacterium. 
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AI. Methods 
AI.I 	Large scale isolation of plasmid DNA (maxiprep) 
DNA isolations were according to Ish-Horowicz and Burke (1981). 
1. 	 A 200ml culture was grown overnight with shaking at 37°C in the presence 
of 100 JIg/ml ampicillin. 
2. 	 The cells were harvested in a GSA centrifuge tube at SOOO rpm for S min. 
3. 	 The pellet was resuspended in 4 ml of Solution I (SO mM glucose, 2S mM 
Tris-HCI, pH 8.0), transferred to a SS34 centrifuge tube and left for S min at 
room temperature. 
4. 	 8 ml of Solution II (0.2 M NaOH, 1 % (w/v) SDS) was added. The tube was 
rolled gently to mix the solutions and was incubated on ice for S min. 
S. 	 6 ml of Solution III (SM potassium acetate (KOAc), pH 4.8) was added, the 
tube was mixed well and incubated for S min on ice. 
6. 	 The debris was spun down at IS 000 rpm for 15 min and the supernatant 
decanted into a new SS34 tube. 
7. 	 An equal volume (about 20 ml) of isopropanol was added and the tube was 
centrifuged at IS 000 rpm for IS min. 
8. 	 The pellet was washed with 70% ethanol, the tube was inverted to drain it 
and the pellet was resuspended in 4.2 ml Tris-EDT A (TE) buffer (pH 8.0). 
S.1S g of cesium chloride (CsCI) was added and dissolved and 200 JIl of 
ethidium bromide (EtBr) (10 mg/ml stock) was added. 
9. 	 The tube was centrifuged at 13 000 rpm for IS min to precipitate any 
remaining protein debris. 
10. 	 The refractive index of the solution was adjusted to 1.394. 
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11. 	 The sample was sealed in a Beckman Quickseal ultracentrifuge tube (5 ml) 
and centrifuged for a minimum of 6 h at 55 000 rpm in a Beckman Vti 65 
rotor at 15 °C. 
12. 	 The plasmid band was extracted in the smallest possible volume from the 
side of the tube using a 1 ml syringe and a 1.2 mm guage needle under long 
wave UV light (350 nm). 
13. 	 The EtBr was extracted at least three times using equal volumes of salt­
saturated isopropanol. 
14. 	 The DNA solution was divided into 166 III quantities. Two volumes 
(333 ~ll) of water and two total volumes (l ml) of absolute ethanol were 
added and the microcentrifuge tubes were spun at 10 000 g in a 
microcentrifuge for 10 min at room temperature. 
14. 	 The pellet was resuspended in 450 IJ.l of TE, 50 Jll of 3M sodium acetate 
(NaAc, pH 5.2) and 1 ml of absolute ethanol. The solution was centrifuged 
as above and the pellet was washed with 70 % ethanol and resuspended in 
100 IJ.l TE. 
15. 	 The concentration of DNA was determined spectrophotometrically by 
measuring the A260 between 210 nm and 310 nm of a 1 in a 100 dilution. 
The relationship A260 = 1 for 50 Ilg/ml of double-stranded DNA was used. 
Al.2 Small scale isolation of plasmid DNA (miniprep) 
The method is a scaled down version of the above maxiprep method. 
1. 	 YT broth containing 100 Ilg/ml ampicillin was pipetted into Eppendorf 
microcentrifuge tubes which were then inoculated and grown at 37 °C with 
vigorous shaking overnight. 
2. 	 Cells were harvested by centrifugation at 10 000 g for 1 min. 
3. 	 200 IJ.l of Solution I was added. The tube was vortexed until the pellet was 
resuspended. 
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4. 	 400 J11 of Solution II was added, the tube vortexed and incubated for 5 min. 
5. 	 300 J11 of Solution II was added, the tube vortexed and after 5 min, the 
cellular debris was precipitated at 10 000 g for 5 min. 
6. 	 The supernatant (750 J1l) was removed to a new Eppendorf, 750 J1l of 
isopropanol was added, mixed and spun at 10000 g for 15 min. 
7. 	 The DNA pellet was resuspended in 450 J1l TE, to which 50 J1l of 3M NaAc 
and 1 ml of absolute ethanol were added and was spun for 15 min. 
8. 	 The pellet was washed with 70% ethanol and resuspended in 20 J11 TE. 
AI.3 Restriction endonuclease digestion of DNA 
Restriction digests were performed according to Sambrook et al. (1989). 
Restriction digests of miniprepped DNA typically contained 2-4 J1l of DNA, 1 unit 
of endonuclease per 100 ng of DNA and 2 J1l of the appropriate restriction 
endonuclease buffer (A2.6) in a total volume of 20 J1l. Restriction digests of large 
quantities of DNA were performed in large (100-200 J11) volumes and then 
precipitated or electrophoresed on agarose gels for DNA fragment purification. For 
restriction of C. acetobutylicum P262 and E. coli JM105 chromosomal DNA, single 
digests of approximately 10 J1g of DNA were performed in 100 J1l volumes for 
1.5 h. The appropriate digests were mixed, after checking for complete digestion, 
additional endonuclease was added and the digestion was allowed to proceed for an 
additional 1.5 h. The enzyme concentration never exceeded 10% of the digest 
volume and star activity in some endonucleases was taken into account by reducing 
the incubation time. 
AI.4 Phenol cleaning of DNA solutions 
DNA restriction digests were phenol cleaned to remove restriction endonucleases 
before commencing restriction with a second endonuclease requiring different 
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restriction buffers or conditions. Phenol cleaning was also used to prepare 
electroeluted DNA fragments for subsequent ligation reactions. 
1. 	 The DNA-containing solution was made up to 450 J11 with TE in order to 
increase the working volume so as to minimise any DNA loss. 
2. 	 One tenth volume (50 J1l) of TE-buffered phenol was added and the tube was 
vortexed. One volume (500 J1l) of chloroform:isoamylalcohol (24:1) was 
added, the tube vortexed again and spun in a microcentrifuge for 5 s. 
3. 	 The top aqueous layer was carefully removed (without any of the protein 
interface) and extracted twice with equal volumes of 
chloroform:isoamylalcohol (24: 1). 
4. 	 The DNA was precipitated by adding 50 J1l NaAc to 450 J1l of the DNA­
containing solution. 1 ml of ethanol was added and microfuged for 10 min 
at room temperature. The pellet was washed with 70% ethanol and 
resuspended in TE buffer. 
Al.S Agarose gel electrophoresis of DNA fragments 
Agarose gel electrophoresis was carried out using horizontal submerged gels 
(Sambrook et al., 1989). Sigma Type II agarose was used (0.8%) in Tris­
acetate EDT A (T AE) buffer. Electrophoresis loading buffer, containing the dye 
bromophenol blue, was added to the DNA samples (1/5 volume of the volume to be 
loaded) before they were loaded into the wells of agarose gels. Long gels were run 
at lOOV constant voltage for about 5 h or overnight at 30V. Slide gels (10 ml 
agarose in total) were routinely used to check whether DNA digests had cut to 
completion and were run at 50V for 30 min. Gels contained 25 J11 of EtBr 
(10 mg/ml stock) in 500 ml of agarose (0.5 J1g/ml) so that DNA bands could be 
visualized using a 254 nm transilluminator. If DNA fragments were to be isolated 
from the agarose gel for subsequent ligation reactions, the 310 nm transilluminator 
was only used for a few seconds. Gel photography was carried out using a Polaroid 
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CU-5 Land camera fitted with a red filter. Polaroid type 667 film (ASA 3 000) was 
used with an exposure time of 1-2 s at f4.7. Standard DNA fragments were 
obtained by digesting lambda (A) DNA with Pstl restriction endonuclease. The 
fragment sizes corresponded in kb in descending order to 14; 11.5; 5.08; 4.75; 4.5; 
2.84; 2.56; 2.45; 2.14; 1.99; 1.7; 1.16; 1.09; 0.81; 0.51; 0.47; 0.45; 0.34; 0.26; 0.25. 
Al.6 Purification of DNA fragments 
The Geneclean Kit (Bio 101, La Jolla, California, USA) was used according to the 
manufacturer's instructions to isolate DNA fragments from agarose gel slices. 
DNA fragments were also electroeluted from agarose gel slices; 
1. 	 The appropriate agarose gel slice (0.8% agarose) was cut out of the gel under 
long wave UV light (310 nm). 
2. 	 The slice was inserted into an 8 cm length of dialysis tubing, clamped at one 
end with a plastic dialysis clip. 
3. 	 0.5 ml of Tris-acetate EDTA (TAE) buffer was pipetted into the tubing, air 
bubbles were squeezed out using gloved fingers and the other end of the 
tubing was clamped. 
4. 	 The tubing was floated in TAE in an electrophoresis tank, secured with 
masking tape to the sides of the tank. The gel slice was placed so that the 
DNA could move from the slice into a region of buffer in the tubing under 
the influence of the electric field. 
5. 	 The slice was electrophoresed at l00V for 30 min and the direction of the 
current reversed for 5 s to release any DNA adhered to the tubing. The TAE 
buffer inside the tubing was removed into an Eppendorf and the DNA 
solution was phenol cleaned in order to remove contaminating nucleases. 
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AI.7 DNA ligation reactions 

Ligation reactions were allowed to proceed overnight at room temperature. 

Ligation reaction volumes were usually 20 J.1.l containing 2 J.1.l of ligation buffer with 

A TP and 1 unit of T4ligase. 

AI.S Exonuclease III shortening of insert DNA 
1. 	 12 Ilg of plasmid DNA was double digested to completion with the 
appropriate restriction endonucleases generating a 3' overhang which is 
susceptible to the exonuclease III enzyme and a 5' overhang adjacent to 
vector sequence which is resistant to the enzyme. 
2. 	 The DNA was precipitated and resuspended in 100 III of exonuclease III 
buffer. 
3. 	 Eleven Eppendorf tubes containing 25 III per tube of freshly prepared SI mix 
were placed on ice. 
4. 	 The tube containing the DNA mixture was equilibrated at 37°C in a water 
bath and at T = 0 a 9 III sample was removed and placed in the fIrst of the 
11 tubes as an undigested control sample. 
5. 	 The shortening reaction was started by the addition of 300 U of exonuclease 
III to the DNA tube, which was mixed well. 
6. 	 While at 37°C, samples (9 J.1.l) were removed from the DNA tube at 20 s 
intervals and were added to the S 1 tubes and mixed well by vigorous 
pipetting. 
7. 	 The Eppendorf tubes containing the S 1 nuxes were raised to room 
temperature and incubated for 30 min. 
8. 	 The SI nuclease was stopped by the addition of 3.5 III of SI stop and by 
placing the tubes at 70°C for 10 min. 
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9. 	 Whether digestion had in fact occurred was conftnned by the electrophoresis 
of 5 ,.11 amounts from every second tube on a slide gel. A smearing of the 
DNA indicated that digestion of the linearized DNA had occurred. 
10. 	 3.4 J.Ll of Klenow mix and 1 J.lI of klenow enzyme were added to each tube 
and left for 5 mins 
at room temperature to blunt the ends of the DNA fragments. 
11. 	 1 J.Ll of dNTP's (0.125 mM) were added to each tube and left for 15 min at 
room temperature to "polish" the ends. 
12. 	 Half of the sample from each tube was added to 60 J.lI of ligation mix 
(ligation buffer. T4 ligase and sterile water) and ligation was allowed to 
proceed for at least 3 h. Competent E. coli cells were transfonned followed 
by minipreparation of plasmid DNA to ftnd the appropriate shortened 
plasmids. 
A1.9 Preparation and transformation of competent E. coli cells 
The method of Chung and Miller (1988) was used for the transfonnation of E. coli 
cells: 
1. 	 A 1/100 dilution (0.2 ml) of an overnight culture was made into 20 mls of 
LB and was grown with shaking at 37°C until the cells reached mid-log 
phase at an A6O(} of 0.4-0.6 units (in approximately 3 h). 
2. 	 The cells were poured into an SS34 centrifuge tube on ice and were collected 
by centrifugation at 5 000 rpm for 5 min. 
3. 	 The pellet was carefully resuspended in 1/10 volume (2 ml) of ice-cold 
transfonnation and storage buffer (TSB buffer) and was incubated on ice for 
a minimum of 30 min. 
4. 	 100 ng of DNA was added to 100 ~Ll of cells in an Eppendorf tube on ice and 
was left to transfonn for 30 min. 
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5. 	 TSB solution (0.5 ml) containing 20 mM glucose was added to each tube and 
the plasmid-borne antibiotic resistance gene was allowed to express at 37°C 
for 30 min. For routine transformation of plasmid DNA expressing the 
ampicillin gene, no expression at 37 °C was required. 
6. 	 100 ~ amounts were plated onto YT plates containing 100 Ilg/ml ampicillin 
or the relevant antibiotic. 
7. 	 Surplus cells were stored at -70°C and when needed were thawed slowly on 
ice for routine plasmid transformations (not ligation transformations). 
AI.IO Alkali DNA blotting 
1. 	 The DNA fragments to be blotted were separated by 0.8% agarose gel 
electrophoresis in T AE buffer overnight. 
2. 	 The DNA was depurinated by soaking the gel in 0.25 M hydrochloric acid 
(HCI) for 15 to 25 min with gentle shaking or until the bromophenol blue 
turns yellow. 
3. 	 The gel was briefly rinsed in distilled water and then soaked in a solution of 
0.5 M NaOH/l.5 M NaCI for 30 min with gentle agitation. 
4. 	 A capillary transfer system was set up. The gel was placed on a clean glass 
plate on top of which was placed the wetted nylon Hybond N+ membrane. 
All bubbles were excluded by rolling a glass pipette over the top of the 
membrane. Three sheets of Whatmann 3MM filter paper were wetted in the 
0.5 M NaOH/1.5 M NaCI solution and were placed on top of the membrane, 
taking care to cut off any overlapping pieces. 
5. 	 A thick layer of paper towels were placed on top and weighted and alkali 
capillary transfer was allowed to proceed overnight without drying out the 
membrane. 
6. 	 The nylon membrane was removed and rinsed in 5xSSC for 5 s to remove 
any adhering agarose. 
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7. 	 The membrane was then ready for prehybridization. 
AI.II Preparation of DNA probe and southern hybridization 
The method followed was according to the instructions of the manufacturer of the 
DNA Labeling and Detection Kit Nonradioactive (Boehringer Mannheim (SA)). 
AI.II.I DNA labeling 
1. 	 1 Ilg of linearized DNA was purified by phenoVchloroform extraction and 
ethanol precipitation and resuspended in a maximum volume of 5 J..Ll. 
2. 	 The DNA was denatured by heating in a water bath at 95°C for 10 min and 
then cooling rapidly in an ice/N aCl bath. 
3. 	 The following was added to a tube on ice: 
1 Ilg denatured DNA in 5 J..Ll 
2 J..Ll hexanuc1eotide mixture (vial 5 from the kit) 
2 J..Ll dNTP labeling mixture (vial 6) 
5 J..Ll sterile distilled water (made up to 19 J..Ll) 
1 J..Ll klenow enzyme. 
4. 	 The tube was incubated for 3 h at 37°C, incubation overnight can increase 
the incorporation of label. 
5. 	 The reaction was stopped by the addition of 2 Jll of EDTA (0.2M at pH 8.0) 
6. 	 The labelled DNA was precipitated with 2.5 III LiCl (4M) and 75 J..Ll of 
ethanol at -20°C which was well mixed and left for 30 min at -70 °C. 
7. 	 The DNA was centrifuged in a microcentrifuge for 15 min and the pellet was 
washed with cold 70% ethanol. 
8. 	 The pellet was resuspended in TE and added to 20 ml of prehybridization 
solution in a plastic tube 
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Al.ll.2 Hybridization 
1. 	 The membrane was allowed to prehybridize for a minimum of 3 h in 
prehybridization buffer in a plastic tupperware at 65°C with gentle shaking 
and the buffer was then poured off. 
2. 	 The probe (in 20 mI volume) was denatured by boiling for 10 min in its 
plastic tube in a water bath and was then placed straight into an ice slurry. 
3. 	 The membrane was placed in a hybridization bag sealed on three sides and 
the 20 mI of hybridization buffer was added, all the bubbles were squeezed 
out and the bag sealed. 
4. 	 Hybridization was allowed to proceed overnight at 65°C. 
5. 	 The probe was poured back into the 20 mI plastic tube and was frozen at ­
20°C for further use. 
6. 	 The membrane was given two 5 min washes in 2xSSC/0.l % SDS. 
7. 	 The membrane was then rinsed in a small volume of O.1xSSC/O.1 % SDS and 
then washed twice for 15 min at 65°C in the same solution. 
Al.ll.3 Chemiluminescent detection 
All volumes are for a membrane size of 100 cm2 
1. 	 The membrane was washed briefly (1-5 min) in wash buffer. 
2. 	 It was incubated for 30 min in 100 mls of buffer 2 (which can then be kept at 
4°C for subsequent use). 
3. 	 The anti-digoxigenin-AP, Fab fragments were diluted 1 :6666.6 in buffer 2 
(3 J.1l in 20 mIs) and kept at 4 °C for up to one week. 
4. 	 The membrane was incubated with 20 mIs of the above for 30 min in a 
plastic tupperware with gentle agitation. 
5. 	 Unbound conjugate was removed by 3 x 10 min washes with 100 mIs wash 
buffer. 
6. 	 The membrane was equilibrated for 3 min in buffer 3. 
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7. 	 The AMPPD® stock solution (10 mg/ml) was diluted 1:200 (200 JlI in 
40 ml) in buffer 3, which can then be stored in the dark at 4°C and reused at 
least 5 times. 
8. 	 The membrane was incubated with enough of the above solution to just wet 
the membrane. The liquid was continually moved over the membrane 
surface by tilting the tupperware container. 
9. 	 The membrane was blotted in between two sheets of blotting paper to 
remove all wet spots, but not to completely dry it. 
10. 	 The damp membrane was sealed in a hybridization bag and was exposed to 
XAR-5 autoradiographic film for 5-15 min. 
Al.12 	Protein analysis 
Al.12.1 Cell-free transcription/translation 
The Promega prokaryotic DNA-directed translation kit was used according to the 
manufacturer's instructions except that one third of the recommended reaction 
volumes was used. 
1. 	 3 Ilg of plasmid DNA suspended in a total volume of 4.7 IJ.l was placed in an 
Eppendorf tube to which the following was added: 
6.7 IJ.l pre-mix minus methionine 

1 IJ.l 35S-methionine 

5 IJ.l E. coli S30 extract. 

2. 	 The tubes were incubated in a heating block at 37°C for 1 h, after which 
17 IJ.l of sample treatment buffer was added. 
3. 	 The samples were denatured in a water bath by heating to 95°C for 3 min 
and were loaded onto a 15% SDS-PAGE gel. 
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Al.12.2 T7 -promoter directed expression system 
The method was according to Tabor and Richardson (1985) and Scholz et al. 
(1989). 
1. 	 E. coli AB 1157 cultures, transformed with pGPI-2 and the exonuclease llI­
shortened clones, were grown overnight in YT in the presence of ampicillin 
(100 Ilglml) and kanamycin (50 Ilglml). 
2. 	 The stationary phase cultures were diluted 1/50 into supplemented M9 
medium, containing ampicillin and kanamycin, and grown at 30°C to early 
logarithmic phase (A600 =0.2-0.4). 
3. 	 5 ml of each culture was pipetted into a sterilin tube and heated in a water 
bath at 42°C for 20 min to induce the 17 polymerase. 
4. 	 40 jll of rifampicin stock (25 mglml) was added to a final concentration of 
200 Ilglml and the cells were grown for 10 min at 42°C. 
5. 	 The cells were then grown for 20 min at 30 °C. 
6. 	 In a 30°C water bath in the radioactive area, 1111 of 35S-methionine (10 IlCi) 
was added and the cells were pulse-labeled for 5 min. 
7. 	 The tubes were spun at 9000 rpm for 5 min and the pellet was resuspended 
in 30 III of sample treatment buffer and transferred to an Eppendorf. 
8. 	 The samples were denatured by heating them to 95°C for 5 min and 10 jll 
was then loaded onto a 15% SDS-PAGE gel. 
Al.13 Nucleotide sequencing 
Nucleotide sequencing was according to the dideoxynucleotide triphosphate chain 
temination method of Sanger et al. (1977). The Sequenase® Version 2.0 DNA 
Sequencing Kit was used according to the manufacturer's instructions (United 
States Biochemical) which uses the 17 DNA polymerase (Sequenase®) enzyme. 
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Al.13.1 Primer annealing reaction 
1. 	 IOllg of freshly maxiprepped DNA in TE buffer was diluted to 18 III with 
sterile distilled water. 
2. 	 2 III of 2M NaOH was added and the tube was incubated at 37°C for 
30 min. 
3. 	 The tube was placed on ice immediately and 4 III of 3M NaAc and 150 III of 
absolute ethanol at -20°C was added. 
4. 	 The tube was placed at -70 °C for 15 min and then microcentrifuged for 
20 min at 4°C. 
5. 	 500 III of 70% ethanol was added and the tube was centrifuged again so that 
the pellet was spun through the ethanol wash. The supernatant was carefully 
poured off. 
6. 	 The DNA pellet was resuspended in 7 III of sterile distilled water to which 
2 III of Reaction buffer was added and 1 III of primer (2 pmol). 
7. 	 The tubes were incubated in a heating block at 40 °C for 30 min and were 
tapped occasionally to mix the contents. 
8. 	 The tubes were placed in a beaker of water at 40 °C and were allowed to 
cool slowly to room temperature. The beaker could also be placed in the 
fridge overnight. 
Al.13.2 Sequencing reactions 
1. 	 Termination tubes were fIrst prepared: 1.5 III of termination mix for one 
dNTP and 1.0 III of extension mix was mixed in a single tube, 0.25 III of 
DMSO was added (the quantities were scaled up for the number of 
templates) and then aliquoted in 2.5 III quantities into termination tubes 
marked A, C, G or T. These tubes could be stored at 4 °C for a few h. 
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2. 	 The labeling mix was prepared on ice and the amount per template was: 
1.0~ DTT 
1.7 ~ DMSO 
0.125 III Pyrophosphatase buffer 

2~ Labeling mix minus dA TP 

1.63 III Enzyme Dilution Buffer (scaled down if the amount of 35S_ 

dATP was increased). 

0.25111 17 polymerase (kept at -20°C) 

0.5 ~ 35S-dATP 
3. 	 The template tubes were placed in a water bath at 10-18 °C and 8111 of the 
labeling mix was added to each tube for exactly 4 min. 
4. 	 The termination tubes (A, C, G, T) were prewanned in a heating block to 
48 °C for 30 s. 
5. 	 3.8 ~ from the template tube was aliquoted into each of the four termination 
tubes, mixed by pipetting and incubated for exactly 10 min at 48 °C. 
6. 	 1 III (0.25 UIIlI) of klenow enzyme was added and mixed into each tube and 
the incubation continued for 4 min. 
7. 	 5 ~ of stop solution was added to each tube. Prior to electrophoresis, the 
samples were denatured at 95 °C for 3 min and then placed on ice. 
8. 	 3-4 III amounts were run on 6% polyacrylamide gels for 2 to 6 h at 96 Watts 
using TBE buffer. 
9. 	 The gel was dried at 80°C onto Whatmann 3MM blotting paper using a 
Dual Temperature Slab Gel Dryer (Hoefer Scientific Instruments, San 
Francisco, USA) for 60 min and then exposed to XAR-5 autoradiographic 
film for a minimum of 16 h. 
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Al.14 RNA work 
Care was taken to avoid contamination with ribonuc1eases: 
1. 	 Glassware and pipettes were baked at 200 °C for 4 h. Glassware was also 
rinsed out with chloroform (in the fume hood) and then rinsed in RNase-free 
water instead of baking. 
2. 	 All plastic ware (gel trays, plastic lids) was soaked in a 5% solution of 
hypochlorite (Jik) for 30 min and then rinsed at least three times with 
RNase-free water. 
3. 	 All water used was Millipore-Q water and was therefore RNase-free. 
4. 	 Gloves were used at all times to reduce RNase levels. 
5. 	 Chemicals were used off the shelf and tips were not prepared specially. 
Al.14.1 RNA isolation from E. coli JMIOS and C. acetobutylicum P262 
The method used was according to Aiba et al. (1981). 
1. 	 An E. coli overnight culture was diluted 1:125 (200 Jil in 25 ml) in YT and 
grown for about 3 h until A650 = 0.4-0.5. 
2. 	 C. acetobutylicum spore stock (50 Jil) was heat shocked at 70°C for 3 min 
and placed straight onto ice. 10 J1l was inoculated in the anaerobic box into a 
hungate tube containing Clostridium basal medium (CBM). This tube was 
placed at 37°C with shaking for 11 h until an ~50 = 0.05 was reached and 
then placed on ice overnight. 100 J1l of this culture was used to inoculate 
two 10 ml hungate tubes which were grown for 12 h at 37°C until 
A650 = 0.5. 
3. 	 Both cultures were now treated in the same way: 25 ml of culture was 
poured over about 30 ml of ice in an SS34 centrifuge tube and pelleted at 
5 000 rpm for 8 min at 4°C. 
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4. 	 The pellet was resuspended in 125 III of ice-cold 
O.3M sucrose/O.OIM sodium acetate (pH 4.5) and transferred to a microfuge 
tube. 
5. 	 1251J.l of O.OIM sodium acetate (pH 4.5)12% SDS was added to the tube. 
The tube was heated in a 65°C water bath for 1.5 min. 
6. 	 250 III of hot phenol (heated to 65°C in a water bath in a fume hood) was 
added to the sample, vortexed and incubated for 3 min in the water bath. 
7. 	 The tube was placed in -70°C ethanol in a plastic beaker until frozen and 
then microfuged for 5 min. 
8. 	 The aqueous layer was decanted and extracted with hot phenol two more 
times. 
9. 	 30 IJ.l of 3M NaAc (l1l0 volume) and 900 III of absolute ethanol (3 volumes) 
were added to precipitate the RNA. The tube can be stored at -70°C 
overnight at this stage. 
10. 	 After precipitation for at least 5 min at -70 °C, the tube was spun at 4 °C for 
10 min, the pellet washed with 70% ethanol and respun for 10 min across the 
tube. 
II. 	 The pellet was resuspended in 180 IJ.l of Millipore-Q water and 20 IJ.l of 
lOx DNase buffer: 
200 mM NaAc (pH 4.5) 
100 mMMgCl2 

100 mMNaCl 

12. 	 30U of RNase-free DNase was added and DNA digestion was allowed to 
proceed for 30 min at room temperature. 
13. 	 The DNase was inactivated by the addition of 20 III of 250 mM EDTA and 
extracted by the addition of 220 III of phenol-chloroform (l: I). The tube 
was vortexed, spun and the top, aqueous layer was decanted. 
14. 	 Chloroform-isoamyl alcohol (24:1) was also used to complete the extraction 
of phenol which may contain contaminating RNases. 
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15. 	 The RNA was precipitated with 1/10 volume of 3M NaAc and 3 volumes of 
ethanol and washed with 70% ethanol, as above. 
16. 	 The RNA pellet was resuspended in 40 Jll Millipore-Q water and was stored 
at -70°C. The concentration was determined spectrophotometrically using 
the relationship A260 = 1 for 25 ~g/ml of single-stranded RNA. 
Al.14.2 Denaturing RNA gel electrophorsis 

RNA gels were run according to Fourney et al. (1988). 

1. 	 A 13 x 24 cm gel tray, comb and gel tank were soaked overnight in 5% 
hypochlorite and rinsed well with Millipore-Q water. 
2. 	 1.5 g agarose and 10 ml10xMOPS and 87 ml Millipore-Q water were mixed 
and microwaved to dissolve the agarose. 
3. 	 When the mixture was about 70°C, 5.1 ml of 37% formaldehyde was added 
in a fume hood (the mixture thickened on addition). 
4. 	 The gel was poured and allowed to set for at least 1 h. 
5. 	 Prior to loading, the wells were flushed with 1xMOPS (running buffer). 
6. 	 Less than 10 ~g per lane was run on a slide gel to check the relative 
concentrations of RNA, 30 ~g was run per lane for the Northern blot. 
7. 	 A maximum RNA sample volume of 10 Jll only, was loaded. The volume 
should be adjusted to at least 5 ~l with RNase-free water 
8. 	 20 Jll of Electrophoresis sample buffer was added, the tubes heated to 65°C 
for 15 min and then placed straight onto ice. 
8. 	 1 Jll of EtBr (1 mg/ml) was added per sample. 
9. 	 The gel was run at 30V overnight. 
Al.14.3 Random primed labeling of DNA probe with [32aP]-dCTP 
The DNA probe was prepared according to the instructions of the Random Primed 
DNA Labeling Kit (No. 1004 760), Boehringer Mannheim (SA). 
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1. 	 100 ng of DNA in a 9 ~ volume was denatured by heating for 10 min at 
100 °C and rapid cooling on ice. 
2. 	 The following were added to the microfuge tube on ice: 
dA TP (vial 2) 1 III 
dGTP (vial 4) 1 III 
dTIP (vial 5) 1 III 
reaction mix (vial 6) 2~ 
[32a.P]-dCTP 5~ 
H2O to 19~ 
Klenow enzyme (2U) 1~ 
3. 	 Labeling was allowed to proceed for 2 hat 37°C in a heating block. 
4. 	 The reaction was stopped by the addition of 2 III of 0.2M EDTA (pH 8.0). 
5. 	 1 ~ of the reaction mixture was diluted in 19 ~ of distilled water and was 
carefully spotted onto two small pieces of filter paper in two 1 0 ~ amounts. 
6. 	 The paper was allowed to air dry and one was then washed with ice-cold 
trichloroacetic acid (TCA) for 10 min to precipitate the DNA. 
7. 	 The paper was then given two ethanol washes of 10 min each and then air­
dryed. The filter papers were placed in two scintillation vials and the 
amount of radioactivity present measured in a scintillation counter. The 
incorporation of radioactivity was the ratio of the amount of radioactivity on 
the treated filter to the amount on the untreated filter. 
Al.14.4 Northern hybridization 
Northern hybridization was according to the Hybond N+ protocol for nucleic acid 
blotting and hybridization (Amersham International, UK). 
1. 	 A plastic tupperware box and vacuum blotting equipment was soaked 
overnight in a 5% solution of hypochlorite and rinsed well. 
98 Appendix 
2. 	 The RNA gel was soaked for 20 min in 0.05M NaOH with gentle agitation 
and then vacuum-blotted for 45 min onto Hybond N+ in the same solution. 
3. 	 The membrane was rinsed for 1 min in 2xSSPE. 
4. 	 Prehybridization and hybridization were performed in: 5xSSPE, 
2xDenhardt's solution, 0.1% (w/v) SDS, 50% (w/v) formamide and 
0.1 mg/ml denatured salmon sperm. (The pH of the formamide was reduced 
from approximately 8.5 to 5.5 by equilibration with a Duolite MB6113 
mixed resin.) 
5. 	 The membrane was rinsed once in 1xSSPE/0.1 % SDS (w/v) and then 
washed for 15 min in the same solution at 60°C. 
6. 	 The membrane was wrapped in clingwrap and exposed to XAR-5 
autoradiographic film. 
A2. ButTers and solutions 
Standard buffers and solutions are from Sambrook et al. (1989). Solutions were 
autoclaved at 121°C for 15 min or filter sterilized through a 0.22 JlIll Millipore 
filter. 
A2.1 Tris-EDT A (TE) butTer (pH 8.0) 
Tris base 1.21 g 
EDT A (0.5 M, pH 8.0) 2.0ml 
Distilled water to 1.0 I 
The pH was adjusted to 8.0 with 0.1 M HCl. 
A2.2 	SO x Tris-Acetate EDTA (T AE) butTer (pH 8.0) 
Tris base 242.0 g 
Glacial acetic acid 57.1 ml 
EDTA (0.5 M, pH 8.0) 100.0 ml 
Distilled water to 1.0 I 
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A2.3 10 x Tris-Borate EDTA (TBE) butTer (pH 8.0) 
Tris base 108.0 g 
Boric acid 55.0 g 
EDTA (0.5 M, pH 8.0) 20.0 ml 
Distilled water to 1.01 
A2.4 Gel electrophoresis loading butTer 
0.25% bromophenol blue 0.05 g 
25% Ficoll (Type 400) 5.0ml 
EDTA (0.5 M, pH 8.0) 1.6 ml 
Distilled water to 20.0ml 
A2.S Universal restriction enzyme dilution butTer 
Stock solution Final conc /10.0 ml 
Tris-CI (I M, pH 7.5) 10mM 0.1 ml 
NaCI (5 M) 50mM 0.1 ml 
Distilled water 5.3 ml 
Filter sterilize then add 
2-Mercapto-ethanol 10mM 7.0~ 
Gelatin (10 mg/ml) 100 ~g/ml 0.1 ml 
Glycerol 44% (v/v) 4.4ml 
Store at -20 °C. 
A2.6 Restriction enzyme butTers 
The four buffers at 0,50, 100 and 150 mM NaCI are stored at -20 °C. 
Stock solution 0 50 100 150 
Tris-CI (1M, pH 7.9) 1 ml 1 ml 1 ml 1 ml 
MgCl2 (1 M) Iml 1 ml 1 ml 1 ml 
DTT (0.5) 0.2ml 0.2ml O.2ml 0.2 ml 
BSA (10 mg/ml) 1 ml 1 ml 1 ml Iml 
NaCl (0.5 M) 0 1 ml 2 ml 3 ml 
Sterile water 2.4 ml l.4ml OAml 2.4ml 
Glycerol 4.4 ml 4.4ml 4.4ml 4.4ml 
Add all components to a sterilin tube and make up to the 10 ml mark with glycerol. 
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A2.7 10 X Ligation butTer 
Stock solution 
Tris-CI (1 M, pH 7.6) 
MgCl2 (1 M) 
DIT (1 M) 
ATP (0.1 M, pH 7.0) 

Distilled water 

Store at -70 °C. 

Final concentration 
66mM 
6 mM 
100mM 
10mM 
/1 ml 
660 IJl 
661Jl 
100 IJl 
100 JlI 
1741Jl 
A2.8 Exonuclease III shortening solutions 
1. 10 x SI butTer 
KOAc (3 M) 1.1 ml 
NaCI (5 M) 5.0 ml 
Glycerol 5.0ml 
ZnS04 30.0 mg autoclave 
2. Exo III butTer 
Tris-CI (1 M, pH 8.0) 660 IJl 
MgCl2 (100 mM) 66.41Jl 
Distilled water 9.27 mls autoclave 
3. SI mix 
10 x Sl buffer 41 JlI 
Sterile water 2581Jl 
Sl nuclease 60U 
4. SI stop 
Tris base (0.30 M) 
EDTA (0.05 M) 
Autoclave but do not pH since a high pH is needed to inactivate the S 1 nuclease. 
5. Klenow mix 
Tris-CI (20 mM, pH 8.0) 
MgCl2 7mM autoclave 
6. Ligase mix 
lOx ligation buffer 90 IJl 
T4 ligase 121Jl 
Sterile water 6181Jl 
Enough for 12 tubes. Use 60 Jll per tube. 
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A2.9 Transformation and storage butTer (TSB) 
LB 150mI 
PEG (4000) 15 g 
MgS04 (1 M) 1.5 mI 
MgCI2 (1 M) 1.5 mI 
Dispense into 20 ml amounts and autoclave. Add 1 mI DMSO before use and 
glucose to a final concentration of 20 mM. 
A2.10 DNA hybridization solutions 
1. 0.25 M HCI stock 1 I 
HCI (9.1 gil) 33% 23.8 mI 
2. Alkali transfer solution 
NaOH(O.5 M) 20g 
NaCI (1.5 M) 87.7 g 
3. Prehybridization and hybridization butTer 
stock 200mI 
SSC (5 x) 20x 50mI 
Oxoid skim milk powder (1.5%) 3g 
N-Iauroylsarcosine, Na (0.1 %) 0.2 g 
SDS (0.02%) 10% 4OOJ.1l 
Dissolve for 1-2 h at 50°C. 
4. 2 x SSC I 0.1 % SDS 1 I 

SSC (2 x) 20x l00mI 

SDS (0.1%) 10% 20mI 

5. 0.1 x SSC I 0.1 % SDS 1 I 

SSC (0.1 x) 20x 5mI 

SDS (0.1%) 10% 20mI 

6. ButTer 1 21 

Maleic acid (0.1 M) 23.2 g 

NaCI (0.15 M) 17.6 g 

Adjust pH to 7.5 with NaOH pellets and autoclave. 

7. Wash butTer II 

Buffer 1 997mI 

Tween 20 (0.3%) 3mI 

8. Block butTer 

1 % Oxoid skim milk powder in Buffer 1. Microwave on high for 3 min. 
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9. Buffer 3 Stock 500ml 
Tris-CI (0.1 M) 1M 50ml 
NaCI (0.1 M) 5M 10ml 
MgCl2 (50 mM) 1M 25 ml 
A2.11 SDS PAGE solutions 
All solution recipes are contained in the Hoefer Electrophoresis Catalog and 
Exercises (1990-1991) pg 123-126, Hoefer Scientific Instruments, San Francisco, 
California, USA. 
After staining the gel for 20-30 min, the gel was destained 3 x in: 
Methanol (30%) 300 ml 
Acetic acid (10%) 100ml 
Distilled water 600ml 
Gels were stabilised in 3% glycerol for 2 h or overnight. 
A2.12 DNA sequencing gel mix 
6% acrylamide gel mix was used: 
Urea 12.0 g 
Bis acrylamide 0.21 g 
Acrylamide 4.8 g 
10 xTBE 8.0ml 
Distilled water (35 ml) to 80.0 ml 
55 ml of the mix was filtered through a 0.8 J.l11l Millipore filter. 50 JlI of TEMED 
and 50 JlI of 50% ammonium persulphate was added and mixed before the gel was 
poured. 
A2.13 Denaturing RNA gel solutions 
1. 10 x MOPSIEDT A buffer 

MOPS [3-(N -morpholino )propanesulfonic acid] (0.2 M) 

Sodium acetate (50 mM) 

EDTA(10 mM) 

Adjust pH to 7.0 and autoclave 

2. RNA electrophoresis sample buffer 

Deionized formamide 0.75 ml 

10 EMOPS 0.15 ml 
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Formaldehyde 0.24 ml 
RNase-free water 0.1 ml 
Glycerol 0.1 ml 
Bromophenol blue (10%) 0.08 ml 
Store at -20°C in small aliquots. 
A3. Media 
Solid media contained 1.5% (w/v) agar. Media were autoclaved at 121°C for 
20 min. 
A3.1 Luria-Bertani medium (LB) 
Bacto typtone 10 g per litre 
Yeast extract 5g 
NaCI 5g 
A3.2 Yeast tryptone medium (YT) 
Bacto-tryptone 16 g per litre 
Yeast extract 10 g 
NaCI 5g 
A3.3 E. coli M9 minimal media 
Na2HP04 6g per litre 
KH2P04 3g 
NaCI 0.5 g 
NH4CI 1 g 
The pH of the solution was adjusted to pH 7.4 before autoclaving. The following 
sterile solutions were added after autoclaving: 
Stock /100 ml 
MgS04·7H20 20% 0.1 ml 
CaCI2·2H20 0.1 M 0.1 ml 
Glucose 20% Iml 
For the T7 expression system 100 ml of medium was supplemented with: 
Thiamine (vit B 1) 2 mg/ml 1 ml 
18 amino acids each 1 mg/ml 100 JlI 
(not cys and met) 
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A3.4 Clostridium basal medium (CBM) 

The recipe is according to O'Brien and Morris (1971). 

Stock /l 
Glucose 10 g 
Sigma casein hydrolysate 4 g 
Difco yeast extract 4g 
MgS04·7H20 20% Iml 
MnS04·4H20 1% Iml 
FeS04·7H20 1% Iml 
PAB 0.1% Iml 
Biotin 0.002% Iml 
Thiamine HCI 0.1% I ml 
After autoclaving add: 
NaHC03 10% 10ml 
Cysteine HCI 5% 10ml 
Resazurin stock solution (not for plates) 2ml 
A4. Antibiotics and media additives 
Concentration Stock 
Ampicillin 100 J1lIml 100 mg/ml in water 
Kanamycin 50 ~/ml 25 mglml in water 
Rifampicin 200 ~/ml 50 mg/ml in DMSO 
Metronidazole 0-50 J.1Vml 5 mglml in water 
Only kanamycin and metronidazole were filter sterilized. Ampicillin was divided 
into I ml amounts and stored at -20°C. 
IPTG (isopropy l-b-D-thio-galactopyranoside) 
IPTG (100mM) 23.4 mg 
Distilled water I.OmI 
The solution was aliquoted and stored at -70°C. 
X-Gal (5-bromo-4-chloro-3-indolyl-b-galactoside) 
X-Gal (2% w/v) 0.2 g 
Dimethylformamide 10.0 ml 
The solution was stored at -70°C. 
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